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In Swaziland, cases of cervical cancer among Human Immunodeficiency Virus (HIV)-
positive adolescent girls and young women (AGYW) are increasing, but there is low uptake 
of cervical cancer screening. This study was conducted using the systems thinking theory to 
explore the relationships between the uptake of cervical cancer screening among HIV-
positive AGYW in Swaziland and the availability of trained health providers, cervical 
screening services, and the provision of referrals for cervical screening. The study also 
investigated any differences in uptake of cervical screening based on age group. For this 
quantitative cross-sectional study, secondary HIV program data that were collected routinely 
between January 2016 and March 2018 were accessed. Data were described with univariate 
analysis while relationships were tested using bivariate analysis and logistic regression. 
Most facilities (97%) had staff who had been trained; facilities with greater numbers of 
trained staff were more likely to have a higher uptake (OR: 30.3, p = 0.000). Facilities with 
cervical screening services were also more likely to have a higher uptake (x2 = 16.94, p = 
0.000), and facilities with all the core components for screening had the highest uptake (p = 
0.002). AGYW who had a positive screen were referred equally but the referral rate was low 
(20.45%). There was no difference in uptake by age group. The results of the study can 
increase knowledge of the institutional factors that contribute to the low uptake of cervical 
cancer screening among HIV-positive AGYW and has implications for social change by 
informing interventions for improving cervical cancer screening uptake in HIV-positive 
AGYW in similar settings, ultimately reducing the high costs, morbidity, and mortality 









MPH, Manchester University, 2012 
MMed Internal Medicine, Makerere University, 2005 




Doctoral Study Submitted in Partial Fulfillment 
of the Requirements for the Degree of 








To my inspiration and perpetual cheer leader, my late mother Nina Blick-Calnan; she 
believed her children were destined for great things and kept pushing us to excel beyond all 
expectation. I owe it all to you! To my father, Jack Calnan, who gave his children all the 
opportunities we needed to succeed in life even during the difficult years, my gratitude is 
forever. 
I am deeply grateful to my husband Andrew, my sons Michael (Mickey), Aidan and 
Matthew, who have provided their constant love, support and understanding and kept me 
afloat. I love you all to eternity. To my siblings Helen, Jackie, Sonya, Jack Jr, Brian and 
Georgette, who have provided me with emotional and moral support throughout my life, I 
am forever indebted. I am also grateful to my ‘sisters’ Mildred, Lydia and Nondumiso your 
constant encouragement and knowing you had my back made all the difference. Thank you 
for crying and laughing with me along the way. 
I would like to acknowledge and give my warmest thanks to my supervisor, 
Professor Peter Anderson, who made this work possible. His friendly guidance and expert 
advice have been invaluable throughout all stages of the work. I also want to express my 
gratitude to Professor Vasileios Margaritis for his valuable suggestions which have 
contributed greatly to the improvement of my thesis. Thank you both very much. 
Lastly, but not least I want to thank all my HIV-infected patients who have 
influenced my career and provided me with the resilience to keep on working even when it 
felt like I had nothing more to offer. Thank you very much. 
 
i 
Table of Contents 
List of Tables .......................................................................................................................v 
List of Figures ................................................................................................................... vii 
Section 1: Foundation of the Study and Literature Review .................................................1 
Introduction ....................................................................................................................1 
Problem Statement .........................................................................................................3 
Purpose of the Study ......................................................................................................4 
Research Questions ........................................................................................................5 
Theoretical Framework ..................................................................................................7 
Nature of the Study ......................................................................................................10 
Literature Review Search Criteria ...............................................................................12 
Literature Review .........................................................................................................13 
HIV-infected Adolescent Girls and Young Women ............................................. 13 
Cervical Cancer Screening ...........................................................................................14 
Burden of Cervical Cancer .................................................................................... 14 
Importance of Addressing Cervical Cancer Burden ............................................. 16 
What is Cancer of the Cervix? .............................................................................. 16 
What Causes Cancer of the Cervix? ..................................................................... 17 
What are the Main Risk Factors? .......................................................................... 17 
Cervical Cancer Prevention .................................................................................. 19 
Cervical Cancer Screening Programs ................................................................... 21 
Cervical Cancer Screening in Swaziland .............................................................. 23 





Scope and Delimitations ..............................................................................................36 
Significance, Summary and Conclusions ....................................................................37 
Section 2: Research Design and Data Collection ..............................................................40 
Introduction ..................................................................................................................40 
Research Design and Rationale ...................................................................................40 
Rationale for Secondary Data Analysis ................................................................ 42 
Methodology ................................................................................................................43 
Population ............................................................................................................. 43 
Data Set ................................................................................................................. 44 
Sampling Procedures Used to Collect Data .......................................................... 45 
Sampling Frame .................................................................................................... 46 
Inclusion and Exclusion Criteria ........................................................................... 49 
Instrumentation and Operationalization of Constructs ......................................... 50 
Data Analysis Plan .......................................................................................................55 
Cleaning the Data .................................................................................................. 55 
Specific Statistical Tests to Examine Each of the Research Questions ................ 57 
Data Analysis ........................................................................................................ 58 
Threats to Validity .......................................................................................................64 
External Validity ................................................................................................... 64 
Internal Validity .................................................................................................... 66 





Data Collection ..................................................................................................... 70 
Descriptive Statistics ....................................................................................................71 
Health Facilities .................................................................................................... 71 
Adolescent Girls and Young Women ................................................................... 73 
Statistical Analysis .......................................................................................................76 
Association Between Trained Health Care Providers and Cervical Cancer 
Screening ................................................................................................... 76 
Availability of Cervical Cancer Screening Services ............................................. 79 
Association Between the Frequency of Services Offered and Uptake of 
Cervical Cancer Screening ........................................................................ 83 
Core Characteristics for Cervical Cancer Screening and its Uptake .................... 85 
Difference in Uptake of Cervical Cancer Screening by Age ................................ 91 
Summary of Results .....................................................................................................94 
Section 4: Application to Professional Practice and Implications for Social 
Change ...................................................................................................................97 
Introduction ..................................................................................................................97 
Interpretation of the Findings .......................................................................................99 
Study Findings and Past Research ........................................................................ 99 
Study Findings and Systems Thinking Theory ................................................... 104 
Limitations of the Study .............................................................................................105 




Implications for Practice ..................................................................................... 107 






List of Tables 
Table 1  Health Facilities in Swaziland that Provide HIV care by Region .......................47 
Table 2  Definitions of Variables .......................................................................................52 
Table 3   Distribution of Facilities that Offer Cervical Cancer Screening by Type, 
Ownership, and Location .......................................................................................73 
Table 4  Distribution of Adolescent Girls and Young Women in Facilities by Age 
and Treatment Status .............................................................................................75 
Table 5  Distribution of Adolescent Girls and Young Women by Age and Facility 
Location .................................................................................................................75 
Table 6  Number of Trained Staff to Conduct Cervical Cancer Screening by 
Facility Type ..........................................................................................................77 
Table 7  Adolescent Girls and Young Women Who Received Screening and 
Number of Trained Staff Available ........................................................................78 
Table 8  Availability of Screening Services and Cervical Cancer Screening 
Uptake ....................................................................................................................80 
Table 9  Likelihood for Screening Based on Availability of Cervical Cancer 
Screening Infrastructure ........................................................................................83 
Table 10  Summary of Facilities and Core Service Characteristics for Cervical 
Cancer Screening ...................................................................................................86 
Table 11  Uptake of Cervical Cancer Screening by Availability of Core Service 
Characteristics .......................................................................................................87 
Table 13  Referrals to Adolescent Girls and Young Women with Positive Cervical 
Cancer Screening by Age .......................................................................................89 
 
vi 
Table 14  Referrals to Adolescent Girls and Young Women by Age Group and 
Facility Type ..........................................................................................................90 
Table 12  Age Group by Screening Status .........................................................................93 
 
vii 
List of Figures 
Figure 1. Post-hoc power analysis .....................................................................................50 
Figure 2. Distribution of types of facilities offering cervical cancer screening services ...73 
Figure 3. Study participant flow ........................................................................................75 
Figure 4. Uptake of cervical cancer screening by frequency of screening services  .........86 







Section 1: Foundation of the Study and Literature Review  
Introduction 
HIV-infected women are affected with cervical cancer because HIV accelerates 
the progression of cervical dysplasia and cancer if they are infected with human 
papilloma virus (HPV; Mbulaiteye, Bhatia, Adebamowo, & Sasco, 2011). In Swaziland, 
cervical cancer is the leading cause of cancer related deaths and fourth leading cause of 
all deaths among women regardless of HIV status (Bruni et al., 2016). The high mortality 
rate for women with cervical cancer in Swaziland is associated with advanced disease at 
diagnosis (Bruni et al., 2016), which is partly due to low rates of early detection 
(Gyenwali, Pariyar, & Onta, 2013). Cervical cancer is classified as an AIDS defining 
illness and therefore cervical cancer screening is recommended within basic HIV care for 
women and screening uptake is a proxy indicator for HIV program performance among 
women (Franceschi & Jaffe, 2007; Ports, Haffejee, Mosavel, & Rameshbabu, 2015). The 
most recent World Health Organization (WHO) guidelines on cervical cancer screening 
recommend screening from the age of 21 and every 3 years after that except in special 
populations like women infected with HIV (WHO, 2013b). The guidelines recommend 
screening at first HIV diagnosis in those with non-perinatally acquired HIV and every 
year after that regardless of age (WHO, 2013b).  
Despite the importance of cervical cancer screening to prevent the morbidity and 
mortality related to cervical cancer, the uptake of cervical cancer screening among HIV-
infected AGYW remains very low in Swaziland (Jolly et al., 2017). Studies that have 
been conducted in other sub-Saharan countries provide multiple reasons for the low 
uptake of cervical cancer screening among women but not among AGYW specifically 
2 
 
(Bayu, Berhe, Mulat, & Alemu, 2016; Rosser, Njoroge, & Huchko, 2016). For this 
review, the reasons have been grouped according to the individual, the social support 
systems, the health systems (institutional), and policy environment (Hoque, Ghuman, 
Coopoosmay, & Van Hal, 2014; Ncube, Bey, Knight, Bessler, & Jolly, 2015; Roncancio, 
Ward, & Fernandez, 2013). Women often do not access screening because they are not 
aware of cervical cancer, are not aware of the availability of the screening services, or are 
afraid of the results of the screening (Kasting et al., 2016; Lyimo & Beran, 2012a). 
Women who access the screening services report that peer support or a community 
referral or a health provider referral influenced their decision to screen (Akinyemiju, 
2012; Bayu et al., 2016; Jia et al., 2013). Health care providers report that they can 
provide screening services if the environment is enabling with policy, guidelines, and 
infrastructure (Brouwers et al., 2011; Ndejjo et al., 2016; Ntekim, 2012). Political support 
for the scale-up of screening services also supports the uptake of the cervical screening 
(Ntekim, 2012).  
Among AGYW, health care access is suboptimal (Dellar, Dlamini, & Karim, 
2015), especially among HIV-infected populations where stigma and discrimination 
related to HIV is predominant (Ralph & Brindis, 2010; Tsai, Lin, Chou, & Lin, 2014; 
Villalobos et al., 2017). In Tanzania, an estimated 50% of adolescents become sexually 
active and about 25% of adolescents give birth, but reproductive health services are 
nonexistent and health care access for pregnant young women is limited (Hokororo et al., 
2015). In Nigeria, adolescents and youth account for 46% of the population but their 
health service use is low. The reasons for the low health care service use include services 
that are not appropriate for adolescents and young people, misinformation or bias toward 
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adolescents who seek reproductive health services, long distances to facilities that 
provide youth friendly services, and the cost of the services (Azfredrick, 2016). In 
Swaziland, there is limited evidence available describing use of health care services by 
AGYW in general with even less evidence of the determinants of cervical screening 
among this population, yet they are the most affected by HIV and cervical cancer is on 
the rise in this group (Finocchario-Kessler et al., 2016a; Kim, Campos, O’Shea, Diaz, & 
Mutyaba, 2013). Thus, I investigated the health institutional determinants of cervical 
cancer screening among HIV infected AGYW in Swaziland to provide evidence that 
public health practitioners may use to inform and improve cervical cancer prevention 
programming to increase cervical cancer awareness, prevention, and early detection 
among HIV-infected AGYW thereby reducing morbidity and mortality caused by 
cervical cancer. 
Problem Statement 
Despite the rise in cervical cancer rates among AGYW, that is expected to double 
over the next 10 years in the HIV-infected populations in sub-Saharan Africa, there is a 
lack of evidence regarding the determinants of uptake of cervical cancer screening in this 
population that could inform interventions (Boardman & Robison, 2013; Bynum et al., 
2016; Finocchario-Kessler et al., 2016). HIV-infected AGYW are a growing population 
in sub-Saharan Africa whose health care needs are not being addressed (Kirby, 2016; 
Ramjee & Daniels, 2013; Sommer, 2011). Due to their positions in society, they are more 
likely to have poor HIV treatment outcomes and present with an AIDS defining illness 
such as cervical cancer (Dellar et al., 2015). The late presentation with cervical cancer 
leads to high morbidity and mortality rates as well as increased health care costs. In 2016, 
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the Swaziland cancer registry showed that out of 2,000 women who received cervical 
cancer screening, 65% were HIV-infected AGYW. Among the HIV-infected AGYW 
who were screened, 45% had cervical abnormalities and 20% had late stage cervical 
cancer, proportions much higher than the AGYW who did not have HIV (Swaziland 
Ministry of Health, 2016). However, cervical cancer is curable when detected early, 
suggesting a lack in the preventative health systems that delay the early diagnosis of 
cervical lesions in the HIV-infected AGYW population in Swaziland. There is a need for 
interventions that promote AGYW’s well-being and longevity informed by evidence 
generated from research (Department of Maternal Newborn Child and Adolescent Health, 
2012; Sommer & Mmari, 2015) such as this study. 
Purpose of the Study 
Cervical cancer is a major contributor of morbidity and mortality among Swazi 
women and especially HIV-infected AGYW (Information Centre on HPV and Associated 
Cancers, 2016; Swaziland Ministry of Health, 2016). These women are at increased risk 
of cervical cancer partly because of their low participation rates in preventative cancer 
screening programs and their HIV infection (Swaziland Ministry of Health, 2015b). 
Therefore, the purpose of this study was to investigate the relationships between health 
care institutional factors and young HIV-infected Swazi women’s participation in 
cervical cancer screening using secondary quantitative data.  
Although there are studies on barriers to the uptake of cervical cancer screening in 
HIV-infected women, no age disaggregation is usually provided though it has been 
established that AGYW are a vulnerable population with their own specific barriers that 
need to be addressed (Bailey, 2012). Understanding the health system barriers for this 
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vulnerable population is critical to reducing the morbidity and mortality rates from 
cervical cancer in this population (WHO, 2013). This quantitative study had four main 
independent variables: the availability of screening services in health facilities, the 
presence of staff who are trained to do cervical cancer screening, the provision of 
referrals to eligible women to attend cervical cancer screening, and age bracket of the 
woman undergoing cervical cancer screening. The dependent variable was the uptake of 
cervical cancer screening. Most of the studies on cervical cancer screening uptake are 
qualitative and do not quantify the extent of the problem or describe significant 
relationships between institutional factors and cervical cancer screening uptake 
(Akinyemiju et al, 2015; Dulla, Daka, & Wakgari, 2017; Kasting et al., 2016; 
Visanuyothin, Chompikul, & Mongkolchati, 2015; Wood et al., 2016). 
Research Questions 
The research questions allowed for the description of the relationship between the 
selected health care institutional factors and the uptake of cervical cancer screening 
among the target population. 
Research Question 1: What is the relationship between the availability of trained 
health providers and the uptake of cervical cancer screening among HIV-positive 
adolescent girls and young women in Swaziland?  
H01: There is no relationship between the availability of trained health care 
providers and the rate of uptake of cervical cancer screening among HIV-positive 
adolescent girls and young women.   
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Ha1: There is a relationship between the availability of trained health care 
providers and the uptake of cervical cancer screening among HIV-positive adolescent 
girls and young women.   
Research Question 2: What is the relationship between the availability of cervical 
cancer screening services in a facility and the uptake of cervical cancer screening among 
HIV-positive adolescent girls and young women in Swaziland? 
H02: There is no relationship between the availability of cancer screening services 
within a facility and the uptake of cervical cancer screening.  
Ha2: There is a relationship between the availability of cervical cancer screening 
services within a facility and the uptake of cervical cancer screening.  
Research Question 3: What is the relationship between the provision of a referral 
for cervical cancer screening among eligible HIV positive adolescent girls and young 
women and the uptake of cervical cancer screening among HIV-positive adolescent girls 
and young women in Swaziland? 
H03: There is no relationship between the provision of a referral for cervical 
cancer screening in eligible women and the uptake of cervical cancer screening. 
Ha3: There is a relationship between the provision of a referral for cervical cancer 
screening in eligible women and the uptake of cervical cancer screening. 
Research Question 4: Is there a difference in uptake of cervical cancer screening 
between HIV-positive adolescent girls and HIV-positive young women? 
H04: There is no difference in uptake of cervical cancer screening between HIV-
positive adolescent girls and HIV-positive young women. 
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Ha4: There is a difference in uptake of cervical cancer screening between HIV-
positive adolescent girls and HIV-positive young women. 
Theoretical Framework 
I used the systems thinking theory to guide the research. The systems thinking 
theory was first proposed by Ludwig von Bertalanffy in the 1940s and further refined by 
Ross Ashby in 1956 (Peters, 2014). Von Bertanalanffy proposed this theory to highlight 
the unity of science (Cordon, 2013). He posited that systems are open to and interact with 
their environments and that their natures can change through gaining new properties 
resulting in continual evolution with improvements (Peters, 2014). Proponents of the 
systems theory posit that for a system to work, all parts are interlinked and support each 
part (Diez Roux, 2011; Luke & Stamatakis, 2012).  
The health system needs to improve to address safety, quality, and cost and 
become more patient centered and focused on patient health outcomes. One method that 
has been used in other industries to address similar gaps is a systems thinking approach to 
improvement (Peters, 2014). The systems approach has not been used traditionally in the 
health industry; however, industries that have used a systems approach have reported 
improvements in quality and value. A systems approach incorporates all elements that 
influence health and their interactions (Jeffcott, 2014; Leischow & Milstein, 2006). 
However, there is a challenge in addressing the cultural, structural and technological 
barriers and is further compounded by ensuring that the health improvements are centered 
on the patients and engage the patients (Cordon, 2013).  
Shortfalls occur in health care despite health care providers spending time and 
effort caring for the patients, illustrating that the problem may be with the design and 
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implementation of the multiple systems in health care. The more complex the health care 
required by the patients, the more likely they are to experience multiple incidences of 
harm including the loss of dignity and respect (Arnold & Wade, 2015; Roberts, Fisher, 
Trowbridge, & Bent, 2016). One instance of harm is the failure to provide patient with 
relevant care like AGYW who should receive cervical cancer screening but do not 
(Peters, 2014). Many of the public health programs add unnecessary burden to clinical 
work and remove the focus from the patient (Parham et al., 2015). The lack of standard 
procedures and measurements leads to issues in providing care (Black, 2013; Reeve et al., 
2013). The introduction of technology into health systems has also affected efficiency 
and limited interoperability between data repositories, making health systems even more 
unwieldy (Gaynor, Yu, Andrus, Bradner, & Rawn, 2014; Iroju, Soriyan, Gambo, & 
Olaleke, 2013). However, if e-technology for health were incorporated adequately, 
productivity would increase and health care costs related to data would reduce (Cardoso, 
Marins, Portela, Abelha, & Machado, 2014; Iroju et al., 2013). The solution to the 
challenges in the health care system is to understand and attempt to address the 
nonfunctioning processes and to use a systems approach in doing so (Braithwaite, 2018; 
Carayon et al., 2014) and create a sustainable health system that promotes and supports 
the practice of the health care provider. 
A systems approach can improve health care by considering the multiple elements 
involved in providing care for patients and the multiple determinants of health. 
Understanding the functioning and interactions of these elements can help plan, design, 
and integrate processes, policies, organizations, and people to provide cost efficient 
health care (Elkins & Gorman, 2013). The systems theory approach can be applied to all 
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levels of the health system such as the health facility, regional health management teams, 
public health programs, and the ministry of health officials. Specific tools that include 
problem identification tools, resource use, and human factor engineering to identify 
safety, quality, and reliability challenges are used in the application of the systems theory 
(Cordon, 2013). Additionally, using a systems approach requires data management 
systems, supportive leadership, engagement of patients, families and health care 
providers, and a potential to remodel the existing health care pathways (Htway & Casteel, 
2015).   
Systems thinking concepts in health care can apply to any health care system from 
prevention of disease to end of life care. Public health systems are multilayered and 
multifaceted and for each layer to function optimally, there should be close interactions 
between relevant layers or facets (Peters, 2014). This consists of policy makers both in 
the local environment like the local government and the external environment like the 
WHO as well as structures and groups of individuals in institutions and agencies that 
influence and implement the way health care is delivered. The components of systems 
thinking include the environment in that the system exists; the inputs like technology, 
workforce, infrastructure, quality management; expected outputs like people receiving 
care they need; the processes involved like screening, diagnosis, treatment; the hierarchy 
that governs the system from policy makers to care providers; whether the system is goal 
-driven; and information available regarding the system.   
Failures of cervical cancer screening programs have been attributed to failures in 
system quality management rather than failure of technology (Nygård, 2011). The goal of 
the systems quality management is to confirm that women in targeted demographic 
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groups are screened and receive appropriate follow-up (McGraw & Ferrante, 2014). The 
parts of the system are related to the four-level model of health systems (individual, 
interpersonal, institution, and community), that can be used to outline the factors that 
affect the uptake of cervical cancer screening in targeted groups of women (Huchko, 
Bukusi, & Cohen, 2011). For this research, I focused on the institutional or supply-side 
factors and the health care providers, cervical cancer screening infrastructure, and patient 
management systems in the current health care system in Swaziland. 
Nature of the Study 
The nature of this study was quantitative. The methodology of a study is 
determined by the issue the researcher is examining, the research questions, and the type 
of data to be analyzed (Kothari, Kumar, & Uusitalo, 2014). Because secondary data were 
used in this study, it was a cross-sectional analytical retrospective survey (Rabinovich, 
2011). Data were sourced from the Ministry of Health’s Health Management Information 
Systems (HMIS). All AGYW registered in HIV care were eligible for inclusion in the 
data review. Data were triangulated from the national service availability and readiness 
assessment (SARA) 2017, the HIV client management system, and the national training 
information system. The common denominator to these datasets was the unique facility 
identity number.  
The independent variables included:  
• the availability of screening services in health facilities, that involved cervical 
cancer screening equipment, the ability to perform on-site treatment or link 
patients to appropriate treatment services, advertisement of screening services 
in the clinic service listing. 
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• the presence of staff who are trained to do cervical cancer screening as 
recognized by the sexual reproductive health program as being able to 
perform the screening. 
• the provision of referrals to eligible women to attend cervical cancer 
screening. Health care providers are required to complete and provide the 
national referral form for screening services and the referral should be 
documented in the facility registration logbook. Hence, this variable was 
extracted to calculate the proportion of eligible women provided with a 
referral and whether there is a significant relationship between providing a 
referral and uptake of the screening. 
• the age bracket of the woman undergoing cervical cancer screening. The 
young HIV-infected women were disaggregated into adolescents 15-18 and 
young women 19-24. Due to transition in maturity, lifestyle, and legal rights 
that happen between these ages, the uptake of cervical cancer screening 
services was expected to be different between the two age groups. 
The dependent variable was the uptake of cervical cancer screening, that was 
defined as the acceptance and receipt of cervical cancer screening in an eligible woman 
or women. Additional factors that were assessed include locality of the clinic (rural or 
urban) and ownership of the facility, as these may impact on the availability of the cancer 
screening services. The key study variables were extracted into one database and 
analyzed. The data were described using univariate analysis and bi- and multi-variate 
analyses including binomial logistic regression were conducted to test relationships using 
SPSS software.  
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Literature Review Search Criteria 
In this section, I review the public health literature related to cervical cancer 
screening among HIV-infected AGYW. Where the literature was limited or unavailable, 
reference was made to HIV-infected women in general. I identified the need for 
continued research to examine the systemic factors that determine uptake of cervical 
cancer screening among HIV-infected AGYW in Swaziland. Several studies have 
identified the importance of youth friendly services that incorporate cervical cancer 
screening and reproductive health (Hokororo et al., 2015; Jolly et al., 2017; Miller, 
Hanson, Johnson, Royalty, & Richardson, 2014; Mwaniki et al., 2014), but there is still a 
lack of literature providing evidence on the barriers to cervical cancer screening among 
HIV-infected AGYW despite cervical cancer being on the rise in this population.  
I conducted the literature search from peer-reviewed journals, WHO, and cervical 
cancer organizations as well as country level reports on health care access to services for 
AGYW. The databases included MEDLINE with full text, Science Direct, Science 
Citation Index Expanded and CINAHL Plus with full text. The search terms key phrases 
and words included HIV infected adolescents, HIV infected young women, Cervical 
cancer Screening, Cervical cancer screening programs, Cervical Cancer Prevention. I 
considered articles that were published from 2013 to now. Seminal works in adolescent 
reproductive health that were older than 5 years were also reviewed if they had additional 
information on the variables being explored. The articles that contributed to the literature 
presented were entered into a matrix that outlined the article title, purpose of the article, 




HIV-infected Adolescent Girls and Young Women 
Young women are defined as girls and women between the ages of 15 and 24. 
However, because of the significant transition in maturity, lifestyle, and legal rights that 
happen between these ages, they are further subdivided as adolescent girls 15-18 and 
young women 18-24 (Dellar et al., 2015). This distinction is important to design 
interventions that address the vulnerabilities of each age group (Abdool Karim, Baxter, & 
Birx, 2017). For instance, sexually active adolescent girls are increasingly being 
recognized as a population distinct from adult women (Boardman & Robison, 2013; 
Bynum et al., 2016). They are at a high risk of acquiring the HPV, but most infections 
and cervical intraepithelial lesions caused by HPV are cleared by the immune system, so 
most recent guidelines for cervical cancer screening do not recommend routine screening 
in women less than 21 years of age (WHO, 2013b). However, a retrospective review of 
the data in an academic medical clinic in the United States showed that there may be an 
increased risk of developing invasive cancer between the recommended screening 
intervals (Nitschmann, May, Mirkovic, & Feldman, 2016).  
HIV-infected AGYW who are sexually active form a special population requiring 
cervical cancer screening because the incidence of preinvasive cervical cancer (cervical 
intraepithelial neoplasia), as confirmed by colposcopy, is 4 to 5 times higher in HIV-
infected women and adolescents compared to HIV-negative women and adolescents with 
high-risk sexual behaviors (Memiah et al., 2012). Cervical intraepithelial neoplasia is 
common in HIV-infected women because: 
• Both HIV and HPV are sexually transmitted  
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• HIV-infected women are more likely to have persistent HPV infection  
• Persistent infection with one or more oncogenic HPV subtypes is a major 
factor in the pathogenesis of premalignant and malignant cervical disease 
HIV-infected women who develop cervical intraepithelial neoplasia tend to have more 
aggressive disease and therefore guidelines for the prevention and treatment of 
opportunistic infections in adults and adolescents including HPV-related disease 
recommend screening should be initiated within 1 year of onset of sexual activity but no 
later than 21 years old, and the screening should continue throughout the woman’s 
lifetime unlike the general population that ends at 65 years old (Grellier & Quéro, 2014). 
These guidelines also recommend that cervical screening be done at the time of the initial 
diagnosis of HIV and repeated every 12 months thereafter.  
In sub-Saharan Africa where the HIV epidemic is concentrated, there is a lack of 
information on cervical cancer screening implementation in women 15 to 24 years old 
(Coleman et al., 2016; Parham et al., 2015). However, studies conducted on women 
generally reveal low rates of uptake of cervical cancer screening from 3% to 33% 
(Boardman & Robison, 2013; Bruni et al., 2016), with resulting high incident rates of 
cervical cancer—age standardized rates between 29.3 and 42.7 (Obi & Ozumba, 2014)—
and high mortality rates from the disease (Bruni et al., 2016; Coleman et al., 2016; 
Maseko, Chirwa, & Muula, 2015c; Obi & Ozumba, 2014) .  
Cervical Cancer Screening 
Burden of Cervical Cancer 
Cancer of the cervix, a preventable and treatable cancer, is a public health issue 
worldwide. It is the fourth most common cancer among women and seventh most 
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common cancer among people globally (Bruni et al., 2016). The age standardized 
cervical cancer incidence and mortality rates in low resource countries are almost twice 
than in higher resource countries where cervical cancer screening is routine (Dunne & 
Park, 2013; Mboumba Bouassa et al., 2017). On an annual basis, about 500,000 new 
cases are reported of which 85% are in developing countries (Bruni et al., 2016). 
Annually 266,000 women die from cervical cancer, and almost 90% of them are in 
developing countries (Finocchario-Kessler et al., 2016). The presence of systematic 
population-based screening in developed countries is to a large extent the reason for the 
large differences in cervical cancer related morbidity and mortality (WHO, 2013). These 
screening programs have reduced incidence and mortality by up to 60% and 75% 
respectively over the last three decades (Vacarella et al., 2016). For example, in England, 
a population-based case-control study that used data recorded between 1998 and 2013 
indicated that screening prevents 70% (95% CI: 66–73%) of cervical cancer deaths (all 
ages), and this was improved among women who were screened regularly to 83% (95% 
CI: 82–84%; Landy, Pesola, Castañón, & Sasieni, 2016). 
Sub-Saharan Africa has the world’s highest age-standardized incidence rates of 
cervical cancer with the highest incidence reported in Malawi (75.9 per 100,000; 
Mboumba Bouassa et al., 2017). Swaziland has the seventh highest age-standardized 
incidence rate at 53.1 per 100,000 women with an estimated 233 women being diagnosed 
annually and 188 dying from the disease annually (Bruni et al., 2016). Despite being one 
of the preventable cancers, cervical cancer is the leading cause of cancer deaths among 
women in Swaziland. Typically, cervical cancer affects women older than 40 years of age 
and progresses very slowly; however, in Swaziland, the epidemiology of cervical cancer 
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has changed due to the high HIV prevalence (32% among people 18-49) and is frequent 
in younger age groups (20-35; Swaziland Ministry of Health, 2016). The cancer is 
aggressive and associated with poor outcomes. Studies and reports developed in 
Swaziland showed that younger women are diagnosed with more aggressive forms of the 
cervical cancer more commonly in the HIV-infected population (Information Centre on 
HPV and Associated Cancers, 2016; Jolly et al., 2017; Malambo & Erikson, 2017; 
Swaziland Ministry of Health, 2016). 
Importance of Addressing Cervical Cancer Burden  
The need to address cervical cancer in developing countries is related to the 
impact on the health of women and by extension their families in society and the impact 
on the health system (WHO, 2013). The social impact of the loss of women in their 
reproductive and economically productive phase in their lives impacts not only their 
families but the society in which they live. Women are responsible for the well-being of 
the family and by extension the community. The impact on the health system is related to 
the prohibitive costs related to treating women with late stage disease that requires 
specialized health care and expensive medications as compared to preventing or detecting 
and treating early stage disease using low cost, low resource cervical screening (WHO, 
2014b). A cost analysis conducted in South Africa found that screening and early 
treatment of cervical cancer precursors cost 80% less than treating invasive cervical 
cancer (Knegt, 2014).  
What is Cancer of the Cervix? 
Cancer is described as an atypical growth of cells (Information Centre on HPV 
and Associated Cancers, 2016). Cancer of the cervix is an abnormal growth of the 
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squamous cells of the cervix (also referred to as the entrance of the uterus). The atypical 
cells mature rapidly, function different to typical cervical cells, and their appearance is 
also different. In advanced disease, the cancer is characterized with invasion of other 
tissues both near and distant from the cervix such as the bladder, bones, and the lungs 
(Aziz & Aziz, 2016). This disease spread is usually via the hematogenous route.  
What Causes Cancer of the Cervix? 
The primary cause of cancer of the cervix is chronic infection with HPV (El-
Khatib, Tota, & Kaufmann, 2012). Known as the silent infection, HPV is one of the most 
common sexually-transmitted infections (Dunne & Park, 2013). HPV infection is cleared 
by about 75% of women who get the infection, and in the remaining 25% who get the 
chronic infection between 60%-70% will go on to develop cancer of the cervix (Ibeanu, 
2011). Cancer of the cervix grows slowly and with little symptomatology until later in the 
disease. Cervical cells that are chronically infected with HPV transform into atypical 
cells that form the precancerous stage, and high grade and anaplastic cells are precursors 
to invasive cervical cancer (Castellsague et al., 2012). Women who may have been 
infected in the teens, 20s, or early 30s may not manifest cervical cancer until 15 to 20 
years later.  
What are the Main Risk Factors? 
There are multiple risk factors associated with the development of cervical cancer, 
but the most important ones include age, immune suppression, HPV infection, sexual 




Age. Any woman who has been sexually active is at risk of developing cervical 
cancer, and the risk increases as a woman gets older. The most consistent predictor of 
risk for cervical cancer is age. However, AGYW are more predisposed for precancerous 
lesions due to their physiology as well as riskier sexual behavior but are more likely to 
clear HPV infections (Van Kerrebroeck & Makar, 2016). 
Immune suppression. Immune suppression, especially related to HIV infection, 
accelerates the development of cervical cancer (Thorsteinsson et al., 2016). Cervical 
cancer is an AIDS defining illness because HIV accelerates the disease progression 
(Kelly et al., 2018; Tirelli, Bernardi, & Vaccher, 2001). Women with HIV and HPV 
infection are 3 times more likely to develop cervical cancer than women who do not have 
HIV (Mukanyangezi et al., 2018; Thorsteinsson et al., 2016). Additionally, the cervical 
cancer in these women is aggressive.  
HPV infection. Between 60% to 70% of the women with chronic HPV infection 
who account for about 5%-15% of women ever infected with HPV will go on to develop 
cancer of the cervix later in life (Petry, 2014). However, research has shown that 
persistent infection with high risk strain types of HPV combined with other factors, such 
as smoking and immunosuppression, cause the majority of cervical cancer cases (Murillo, 
Herrero, Sierra, & Forman, 2016; Richard et al., 2015).  
Sexual behavior. Early sexual debut, multiple sexual partners, and unsafe sex 
increase a woman’s exposure to HPV infection (Martín-Hernán, Sánchez-Hernández, 
Cano, Campo, & del Romero, 2013). Sexual behavior is not an independent risk factor 
for the development of cervical cancer and therefore other risk factors must be present as 
well (Bruni et al., 2016). 
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Smoking, hormonal factors, and genetics. In women with cervical dysplasia, 
tobacco use may play an influencing role in the development of cervical cancer 
(Castellsague et al., 2012; Matsumoto et al., 2010).Early age at first birth, extended use of 
contraceptives, and multiple births influence the development of cervical cancer (Roura 
et al., 2016). Research is providing more information regarding the risk of certain genetic 
profiles in women that predispose them to cervical cancer. However, this is not used 
routinely in the clinical or public health setting (Hu et al., 2015).  
Cervical Cancer Prevention 
Primary prevention and secondary prevention are two interventions that can be 
used for cervical cancer prevention (WHO, 2014b). 
Primary prevention. Primary prevention includes preventing infection with HPV 
or reducing the exposure to HPV infection (McGraw & Ferrante, 2014). Preventing HPV 
infection is achieved through vaccination against HPV in girls and boys who are not yet 
sexually active (El-Khatib et al., 2012). In many developed countries, HPV vaccination 
has been offered routinely since early 2000, while in developing countries, HPV 
vaccination is only starting to be available to vaccination programs. Vaccination against 
HPV has reduced HPV infections by more than 80% in countries where the uptake of the 
vaccination remains at above 75% (McGraw & Ferrante, 2014). Reducing exposure to 
HPV is usually achieved by means of safer sex practices such as delayed sexual debut, 
use of barrier methods during sexual intercourse, and monogamy. Because HPV infection 
does not present with any symptoms in infected individuals and sexuality is a challenge 
to change with varied success, reducing transmission of HPV in the absence of 
vaccination is a major public health challenge. The sexual transmission of HPV infection 
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is driven by many factors other than the individual’s character such as poverty, gender 
norms that promote female subjugation, religious and cultural norms that frown on 
condom use, and situations that expose individuals to sexual violence (Kasting et al., 
2016). 
Secondary prevention (cervical cancer screening). Secondary prevention is 
currently the mainstay for prevention of cancer of the cervix in many developing 
countries while HPV vaccination is being scaled up. Secondary prevention of cancer of 
the cervix involves the early discovery and treatment of high grade precancerous lesions 
of the cervix and more recently testing for the presence of HPV in the cells of the cervix 
even before there are precancerous lesions (Parkhurst & Vulimiri, 2013). Early detection 
of precursors of cervical cancer is achieved through visually examining the cervix using 
different methods. Cervical cancer screening is applied to two groups of women (Randall 
& Ghebre, 2016b):  
• Women who have high grade precancerous lesions in the cervix. The 
development of cancer of the cervix can be curtailed if these lesions are 
diagnosed early and treated promptly.  
• Women who do not have any lesions. Routine HPV testing enables the 
identification of women who are higher risk of developing precancerous 
lesions and allows them to receive cervical screening in a timely manner as 
well as reduce unnecessary cervical screening and cytology. This is an 
important tool in situations where cytology is a challenge like in Swaziland. 
Over the last three decades, cervical cancer screening has evolved from using 
cytology-based tests to DNA testing for HPV and more recently to the availability of self-
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testing, thus improving access to screening for cervical cancer (Boone, Erickson, & Huh, 
2012; Castle & Cremer, 2013; Sarai Racey, Withrow, & Gesink, 2013). However, in low 
resource settings like Swaziland, cytological testing is still the standard practice but has 
evolved from the traditional PAP smear to a “see-and-treat” method with visual 
inspection with acetic acid methodology (Akinyemiju et al., 2015; Lince-Deroche et al., 
2015; Parham et al., 2015). See-and-treat methods reduce the number of visits a client 
needs to make to receive results and treatment thus improving the retention in care as 
well as the access to services and the uptake of the services by the women (Bruni et al., 
2016). Cervical cytology detects early stages of cervical cancer when it can be cured 
preventing the morbidity and mortality associated with cervical cancer.  
Cervical Cancer Screening Programs 
Programmatic evaluations and research have demonstrated that systematic 
cervical cancer screening programs that are carefully planned out, can successfully 
reduce the number of new cases and deaths due to cervical cancer (McGraw & Ferrante, 
2014). In several European countries where population based cervical cancer screening 
programs are institutionalized, the incidence of cervical cancer has decreased by more 
than 60% (Vaccarella et al., 2014). The high mortality due to cervical cancer in 
developing countries has been attributed to ineffective cervical cancer screening 
programs (Randall & Ghebre, 2016b). Evidence suggests that while sixty percent of 
women in high resource countries have undergone cervical cancer screening, only about 
20% of women in low resource countries have undergone a cervical cancer screening 
(Mukakalisa, Bindler, Allen, & Dotson, 2014).  
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The challenges involved in preventing cervical cancer in developing countries are 
numerous however, one major barrier is the inability to have integrated, comprehensive 
and systematic cervical cancer screening programs (Catarino, Petignat, Dongui, & 
Vassilakos, 2015b; Mukakalisa et al., 2014). These programs must have a set of essential 
components (WHO, 2014b) that include: 
• Availability of culturally appropriate informational, educational and 
communication strategies that are informed by audience segmentation to 
create demand for the cervical cancer services within the community.  
• Building capacity of the service providers to increase awareness about 
cervical cancer prevention, how to diagnose and treat early as well as improve 
their skills at conducting the screening. This can be achieved through training 
that addresses both improvements in technical skills and patient education and 
counseling skills.  
• Health facilities are able to provide cervical cancer screening services with 
functional systems to ensure the obtaining and subsequent processing of 
cervical samples are adhered to in a timely and quality assured manner. 
• Health facilities have systems in place to ensure delivery of the results to the 
clients including an active tracking mechanism for women at high risk who do 
not honor their scheduled appointments.  
• The availability of referral and linkage systems for women with abnormal 
results to ensure that these women receive appropriate care interventions in a 
timely manner.  
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• Health facilities that provide cervical cancer treatment are available and 
accessible for women in need of treatment.   
• Monitoring and evaluation systems to ensure availability of statistics and 
information to inform programming. 
Within developing countries in Sub-Saharan Africa, there has been limited impact 
of cervical cancer screening programs mainly because the programs are opportunistic and 
not systematic (Randall & Ghebre, 2016b). The program only reaches women who come 
to health facilities for other health issues or when they are symptomatic for cervical 
cancer. Although the infrastructure to provide the screening services may be available, 
the quality of services provided is weak due to inadequate numbers of trained and skilled 
health providers and there is poor utilization of services by the women due to inadequate 
demand creation  programs to raise awareness, traditional beliefs that prevent the women 
from seeking sexual reproductive health services (gynecological examination is a cause 
of embarrassment or a taboo) or inaccessible health services (Catarino, Petignat, Dongui, 
& Vassilakos, 2015a; Finocchario-Kessler et al., 2016; Kasting et al., 2016). 
Additionally, Health ministries do not invest resources required to maintain a population 
based organized screening service. 
Cervical Cancer Screening in Swaziland 
Over the last three decades in line with the HIV clinical management guidelines 
in Swaziland, there have been multiple attempts to introduce a systematic cervical 
screening program (Jolly et al., 2017). The initial programs were unsuccessful because 
cervical cancer prevention was not a government priority in the face of a raging HIV 
epidemic. The national Health policy does not specifically refer to cervical cancer 
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prevention but makes a general statement that cancer prevention efforts should be 
available within the health care settings (Swaziland Ministry of Health, 2015a). The HIV 
clinical management guidelines provide recommendations for cervical cancer screening 
among the HIV infected girls and women, but cervical cancer screening is not routinely 
or systematically provided to this population. Cervical cancer screening occurs in pockets 
around the country, often in facilities situated in urban areas where access to cytology 
services is easy and almost invariably linked to family planning services (Swaziland 
Central Statistics Office & World Bank, 2014). Thus, women with accessible health care 
and who are often at lower risk for cervical cancer, have more opportunity to receive 
cervical cancer screening and do receive it, while those without access who are often not 
clients of the family planning services are left out. This neglected population includes 
HIV infected AGYW in the rural areas (Fletcher et al., 2014).  
In 2016, the Swaziland Cancer Registry reported that of 2000 women who had 
received a cervical cancer screening, 45% were found to have cervical abnormalities that 
included atypical cells, precancerous cells and early stages of neoplasia of which the 
precancerous cells and early stages of neoplasia are precursors to cervical cancer 
(Swaziland Ministry of Health, 2016). Of those with cervical abnormalities, 62% were 
HIV infected and all were between the ages of 17 and 35 years. The data from the HIV 
information system indicated that there were approximately 300,000 people infected with 
HIV of which 180,000 were women. Adolescent girls and Young women aged 25 years 
and less, made up 38% of this population (Swaziland National AIDS Program, 2016). In 
2015, 3,000 HIV infected women had ever received a cervical cancer screen which was 
less than 2% of the HIV infected female population (Swaziland Ministry of Health, 
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2015b).  These findings illustrate the low coverage of cervical cancer screening services 
in Swaziland that ultimately has a negative bearing on reducing the number of new cases 
of cervical cancer and the number of cervical cancer related deaths.  Furthermore, the 
differences in cervical cancer morbidity and mortality between urban and rural women is 
in part caused by the differences in access to the screening services (Swaziland Central 
Statistics Office & World Bank, 2014).  
In 2015, the Ministry of Health prioritized cervical cancer prevention thus 
demonstrating political will to tackle this issue.  However, since the declaration, there has 
been very little effort by the government to develop a policy or invest resources to 
advance the program, relying on donor funding and implementing partners to implement 
cervical cancer screening within the health facilities. Additionally, the economic 
recession facing the country has hindered the implementation of many vital health 
programs including the cervical cancer screening program. With no guiding policy, 
cervical cancer screening efforts remain at the discretion of the sexual reproductive health 
program, the HIV/AIDS program and individual health facilities and these efforts are not 
coordinated (Jolly et al., 2017; Swaziland Ministry of Health, 2015b; Swaziland National 
AIDS Program, 2016).  
Barriers to Cervical Cancer Screening 
Design and implementation of Public health interventions depend on the 
documentation of the distribution (morbidity, mortality, life expectancy, etc.) and the 
determinants of health including equity, access to and quality of health services. Within 
health services, public health deals with preventive services such as screening or 
vaccination, as well as with health promotion and health care management. Addressing 
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service provision for cervical cancer screening attempts to reduce inequities in health care 
access and quality of cervical cancer preventive services as well as reduce inequalities 
among user groups (Finocchario-Kessler et al., 2016). As mentioned in the previous 
section, WHO recommends seven essential components for service provision of cervical 
cancer screening and available literature from settings similar to Swaziland will be 
reviewed here. There is a dearth in the literature regarding cervical cancer screening in 
HIV infected adolescent girls and what literature there is among young women is often 
not disaggregated for age. There have been few studies in similar settings to Swaziland 
that have evaluated the contribution of institutional system factors to the uptake of 
cervical cancer screening among HIV infected AGYW, whereas there is no published 
data available from Swaziland. With this study, I will attempt to provide evidence of the 
relationships of specific institutional factors and the uptake of cervical cancer screening 
among AGYW. 
Availability of cervical cancer screening services within health facilities. 
WHO defines the availability of cervical cancer screening services within the health 
facility as the presence of infrastructure to offer the screening, the ability of the facility to 
send specimens for cytology and receive results, an information system to monitor the 
implementation of the screening and leadership within the facility to ensure continuity of 
services (WHO, 2014b). In Kenya, the availability of cervical cancer screening services 
in the local clinics despite the availability of the infrastructure was impacted by the lack 
of management capacity within the health facilities to plan for screening services 
(Huchko et al., 2011), whereas in Ethiopia, the lack of appropriate equipment and poor 
infrastructure for both screening and treatment services prevented the implementation of 
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cervical cancer screening within clinics (Gebreegziabher et al., 2016). Additionally, the 
absence of robust communication mechanisms between the different units involved in 
providing cervical cancer screening, diagnosis and treatment services  (McCree et al., 
2015), inadequate health information systems to monitor the screening program and 
failure of outreach programs to reach the at risk women (Fletcher et al., 2014; Kasting et 
al., 2016; Randall & Ghebre, 2016b) have been shown to reduce the availability of 
cervical cancer screening services.  
Comprehensive screening and treatment services that are only provided in urban 
clinics or hospitals limit access to these services. In a low income estate in Durban, South 
Africa, HIV infected women reported a desire to have integrated services in community 
clinics as this improved access for them (Ports et al., 2015). In multiple rural 
communities in Nigeria, women had low knowledge of cervical cancer but were 
interested in finding out more and were anxious to have the opportunity to get screened 
but only if the screening was offered within their community clinics (Nwankwo, 
Aniebue, Aguwa, Anarado, & Agunwah, 2011). In Canada, where opportunistic 
screening has been successful except in the First Nations populations, a qualitative survey 
among health providers revealed that opportunistic cervical cancer screening programs do 
not perform well for First Nations women who experience significant screening-related 
health inequalities that are mainly influenced by structural barriers such as inadequately 
trained health care providers, lack of a recall based screening system as well as 
inadequate structural access and therefore recommend integrated and systematic 
screening for vulnerable populations (Maar et al., 2013). In Swaziland, HIV infected 
AGYW attend HIV clinics regularly for medication refills or for HIV or sexual 
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reproductive health care services including family planning. The HIV and sexual 
reproductive health services are mostly integrated into primary health clinics that offer 
both preventive and curative services (Church et al., 2015). These visits for HIV care can 
be used as an opportunity to implement cervical cancer screening among AGYW. 
However, the absence of routine cervical screening services is a missed opportunity for 
prevention or early diagnosis of the disease among this high-risk population (Murillo et 
al., 2016; Randall & Ghebre, 2016a; Rengaswamy Sankaranarayanan, Anorlu, Sangwa-
Lugoma, & Denny, 2013). While many researchers find that the integration of services 
improves the uptake of services, there is also evidence from community-based studies 
that women are just as likely to access the service if it is available within their local clinic 
regardless of integration or not. Seemingly the uptake of cervical cancer screening is 
influenced by the availability of infrastructure and systems to support the screening 
within each clinic and not only the lack of integration of the services. Based on this 
evidence and using information from the Service Availability Mapping of 2017, I will 
assess the availability of cervical cancer screening services within facilities especially in 
those facilities that provide HIV care and treatment where AGYW receive care.  
Availability of trained health care providers. Health care workers can 
significantly contribute to improvements in cervical cancer screening practices among 
women as they are usually the first point of contact within the health care system 
(Maseko et al., 2015c. In Uganda and Ethiopia, countries with high incidences of cervical 
cancer, poor knowledge of cervical cancer and the rationale for screening as well as poor 
awareness of the available screening guidelines among health care workers have 
hampered the systematic implementation of cervical cancer screening (Dulla et al., 2017; 
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Wanyenze et al., 2017). Assessments of public health approaches to reduce cervical and 
breast cancer have shown that health care workers need be knowledgeable and skilled to 
improve their compliance with the recommended practices that promote prevention 
interventions for cervical cancer such as screening (Liljestrand & Sambath, 2012; Miller, 
Plescia, & Ekwueme, 2014). Studies from South Africa, Zambia and Malawi, countries 
with high HIV prevalence and high cervical cancer incidence have shown that training 
and post training mentorship are two methods to improve health care worker knowledge 
and skills regarding cervical cancer screening (McFarland, Gueldner, & Mogobe, 2016). 
However, training and mentorship alone are not sufficient and health care worker attitude 
that can be a main barrier to screening as it is perceived as “extra work” resulting in 
missed opportunities for cervical cancer screening, needs to be addressed during training 
and mentorship (Brouwers et al., 2011; Paz-Soldán, Bayer, Nussbaum, & Cabrera, 2012). 
In Swaziland, with a doctor population ratio of 10 to 100,000, a nurse population ratio of 
56 to 100,000 and a midwife population ratio of 64 to 100,000, provision of health care 
services is a challenge and therefore the introduction of what is considered a non-
essential service by the health care providers is resisted (Riley et al., 2012; Scheffler, 
2012). Other public health programs in Swaziland like the Swaziland National AIDS 
Program (SNAP) addressed the poor coverage of HIV treatment services by 
implementing task shifting and continuous training and mentoring of health care 
providers to scale up the initiation of Antiretroviral therapy in the country to successfully 
achieve treatment coverage of 82% (Dlamini-Simelane & Moyer, 2017; Mdege, 
Chindove, & Ali, 2013). The sexual and reproductive health program under which 
cervical cancer screening lies, adapted the WHO training package on Cervical cancer 
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screening and is training health care providers in clinics (Jolly et al., 2017; Malambo & 
Erikson, 2017). However, the quality of the training and the continuous mentorship are 
not standardized, and post training evaluations are not available to ascertain the 
competency in terms of knowledge and skills of the providers to offer cervical cancer 
screening to eligible women (Jolly et al., 2017). It is also not known what proportion of 
health care workers who have been trained on cervical cancer screening are actually 
providing the services. Using the national In-service training data base, I assessed the 
number and placement of trained health care providers who are providing cervical cancer 
screening. However, due to the use of secondary data that was limited in the kind of 
variables, it was not possible to evaluate the skills of the trained providers within the 
clinical setting or the quality of the service they are providing. 
Provision of referrals for cervical cancer screening. Women value guidance 
from their providers regarding what to screen for and how to get screened, and are more 
likely to go if they have a provider’s referral (J. J. Kim et al., 2015; Peirson, Fitzpatrick-
Lewis, Ciliska, & Warren, 2013). The provision of referral for services ensures that both 
women and health care providers are making use of available resources within the public 
health sector, the women receive the care they need while the health care workers make 
better use of the available resources within the health system (Wåhlberg, Valle, Malm, & 
Broderstad, 2013). In most sub-Saharan countries with no guiding policies on service 
provision for cervical cancer screening, unavailability of service directories and few 
trained health care providers, the provision of referrals for cervical screening to women 
who are eligible is opportunistic rather than routine (McFarland et al., 2016; Morhason-
Bello et al., 2013; Randall & Ghebre, 2016b). Evidence from Ethiopia and Malawi 
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suggest that referrals are not provided routinely but if women request the service, or the 
health care worker is reminded by either a job aid or a peer, or if they themselves take an 
interest in cervical cancer prevention and awareness activities (Maseko et al., 2015b; 
Roman et al., 2014), referrals for cervical cancer screening are provided and follow up is 
made to ensure that the woman receives the service. In Swaziland, although there is a 
national referral system within the health care system, the referral document is generic 
and not user-friendly for health care providers and neither is there a standardized 
mechanism for the flow of information to and from the sending and receiving facilities 
(Macintyre et al., 2011; MacKellar et al., 2016). The health records system is paper based 
and therefore there are no systematic triggers to remind the health care provider to 
provide a referral for services should the facility not have the services (Macintyre et al., 
2011). A review of the referrals provided for patients who have been newly diagnosed 
with HIV in Swaziland found that only 50% of patients were routinely provided with 
referrals and only 30% of those were ultimately linked to HIV care (MacKellar et al., 
2016). Given that the cervical cancer screening is opportunistic, it is not known how 
many of the eligible women receive referrals for cervical cancer screening and whether 
those who receive a referral, are followed up appropriately. With this study, I evaluated 
the proportion of AGYW in HIV clinics that did not offer cervical cancer screening who 
received a referral and went on to receive the service. With this evidence, it may be 
possible to describe the possible communication loops required to improve the flow of 
information between sending and receiving facilities. 
Differences in uptake of services between HIV-infected adolescent girls and 
young women. For cervical cancer screening to be effective, asymptomatic women need 
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to access the services. This is a challenge because many young people only attend health 
facilities when they are unwell. Additionally, to access a service, the recipient needs to 
know about the service and its benefits (Bayu et al., 2016). Prior studies have shown that 
a major barrier to the uptake of cervical cancer screening is the lack of knowledge among 
women and their communities (Abiodun, Olu-Abiodun, Sotunsa, & Oluwole, 2014; 
Kahesa et al., 2012). Other barriers include fear of the procedure, social and cultural 
norms that do not allow women to expose themselves to people other than their husbands 
or talk about diseases that affect the female reproductive organs, stigma related to sexual 
promiscuity and cervical cancer as well as lack of communication between the health 
care workers and the recipients of care (Idowu, Olowookere, Fagbemi, & Ogunlaja, 2016; 
Jain, Halder, & Mehrotra, 2016). For HIV-infected women, service uptake is hampered 
by limited integration of HIV and cervical cancer prevention and treatment services as 
well as stigma and discrimination (Fletcher et al., 2014). Where integration has happened, 
there is limited tracking of service uptake. There is a paucity of evidence regarding 
cervical cancer screening among HIV infected adolescents and young women in Southern 
Africa but evidence from Europe and North America suggests that adolescents and young 
women tend to be screened unnecessarily creating both management and emotional 
issues for both the adolescent and the service provider (Van Kerrebroeck & Makar, 
2016). However, the European population is different than that found in Swaziland or 
Southern Africa in that, the proportion of adolescents with HIV are few, they can clear 
off the HPV infection with very little untoward outcomes (Boardman & Robison, 2013). 
Despite the recent change in guidelines that do not recommend the routine screening of 
adolescents, there is a provision for the routine screening of HIV infected adolescents and 
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young women due to the recognition of the increased risk of developing cancer of the 
cervix (WHO, 2013). Zambia, a country with the highest cervical cancer rates in Africa at 
58.4 per 100,000, has the largest and most well established cervical screening program in 
Southern Africa (Parham et al., 2015). In 2017, the country reported a total of 90 cases of 
cervical cancer in women aged 15 -24 years, while thirteen countries in Eastern Africa 
reported a total of 901 cases in the same age group (Bruni et al., 2016). In Malawi, 35%-
50% of the cervical lesions detected in young women were found to be in advanced 
stages and screening only took place because they were symptomatic (Maseko et al., 
2015a; Msyamboza, Phiri, Sichali, Kwenda, & Kachale, 2016b; Munthali, Ngwira, & 
Taulo, 2015) Kaufman et al (2016) conducted a systematic review of voluntary male 
medical circumcision in high HIV prevalence Sub-Saharan countries and found that even 
in the presence of adolescent friendly services within health facilities, adolescents will 
not necessarily access the available services in a timely manner. The inability to access 
adolescent sexual and reproductive health services was related to provider incompetency, 
lack of privacy, and limited service availability hours (Kaufman et al., 2016). The lack of 
integrated HIV and sexual reproductive health service delivery points means there are 
missed opportunities for the routine cervical cancer screening of HIV infected AGYW 
(Fletcher et al., 2014; Setse et al., 2012). Despite great progress in the provision of HIV 
services in almost all health facilities in Swaziland, the HIV program is run as a vertical 
program and therefore the integration of services is inconsistent (Obure et al., 2016). 
Obure et al. (2016) went on to compare the integration of HIV and sexual reproductive 
health services in facilities in Kenya and Swaziland and found that in facilities where 
integration had occurred, the quality of care was not any better than in non-integrated 
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sites. They concluded that competent staff in adequate numbers, a robust educational 
program and functional infrastructure play a greater role in delivery of adolescent health 
services. Young women aged 20 -24 years have greater opportunity for cervical cancer 
screening during routine family planning visits, ante- and post- natal care check-up as 
well as during child welfare visits (Lyimo & Beran, 2012b). However, their uptake for 
cervical screening is still poor. Research done in China, Kenya, and Nigeria show similar 
findings that knowledge of cervical cancer and its prevention as well as distance from a 
cervical cancer screening facility are among the main determinants of screening among 
young women (Jia et al., 2013; Ndikom & Ofi, 2012; Sudenga, Rositch, Otieno, & Smith, 
2013). In Swaziland, young women enter the health system during antenatal care where 
they receive the first HIV test, including screening for other sexually transmitted 
diseases. However, due to poor tracking and monitoring systems, there is limited data 
regarding their uptake of services including cervical cancer screening (Mak et al., 2013; 
Tsawe et al., 2015). It would seem from the review of the literature, that the factors that 
prevented young women (20-24 years) from accessing cervical cancer screening are 
slightly different than those affecting adolescent girls (15-19 years) and in the context of 
Swaziland needed to be investigated further to inform the programming of cervical 
cancer screening services given the growing population of HIV infected AGYW. I 
reviewed the data to compare the uptake of cervical cancer screening between AG and 




Adolescent girls and young women (AGYW): Descriptor term for young women 
who lie between the ages of 15 and 24 years. AG are those who fall between 15 and 18 
years and YW fall between 19 and 24 years (Dellar et al., 2015). 
High at-risk population: Subpopulations who are at an increased for a specific 
negative health outcome (Howard & Sacco, 2009). 
Availability of cervical cancer screening in facilities: The WHO provides criteria 
to define availability of cervical cancer screening at a health facility. The criteria include 
the presence of infrastructure to offer the screening, the ability of the facility to send 
specimens for cytology and receive results, an information system to monitor the 
implementation of the screening and leadership within the facility to ensure continuity of 
services (WHO, 2014b). 
Trained health care providers: Health care providers who receive a mandated or 
government approved skills or knowledge building intervention (Ameh & Van Den 
Broek, 2015). 
Referral system: a formal mechanism that allows a client to receive a service 
elsewhere and the mechanism allows for tracking of the client (Gulati & Penn, 2014). 
Assumptions 
The assumption was that all AGYW who were accessing HIV care and treatment 
would have had equal opportunity to hear about cervical cancer screening and that their 
knowledge and attitudes permitted them to participate in preventive care. However, their 
attitudes and perceptions may have prevented them from participating in cervical cancer 
screening despite the availability of all health care components. The other assumption 
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was that all health facilities that had the infrastructure for cervical cancer screening were 
promoting the services and all health care providers who had received training on 
cervical cancer screening would provide the services. In reality, not all facilities with the 
infrastructure for cervical cancer screening were promoting the service and not all trained 
health care providers were providing the screening services. The assumptions were 
necessary to make because the exploration of these institutional factors would highlight 
the factors that play a role in the uptake of cervical cancer screening in the target 
population. Secondary data were used in this study and was assumed to be valid and 
reliable because the data were collected using established measures that had been 
validated by the Strategic Information Department in the Ministry of Health and the data 
contained enough samples to provide a representation of the broader population. 
Scope and Delimitations 
This study extended only to HIV infected AGYW in Swaziland and therefore may 
not be generalizable to non- HIV infected AGYW in Swaziland and HIV infected 
AGYW in other settings whose public health systems may be unlike that of Swaziland. 1 
acknowledge that although there are other contributors to the uptake of cervical cancer 
such as educational level, knowledge of the AGYW, attitudes of the community and the 
AGYW towards cancer screening, culture and health seeking behaviors this study was 
delimited to the exploration of specific institutional (health services) factors that affect 
the uptake of cervical cancer screening among AGYW. The exploration of institutional 
factors is not all encompassing, and I only examined the availability of screening 
services, trained health care providers, the provision of referrals for cervical cancer 
screening and the difference in uptake between AG and YW. The choice of institutional 
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factors was determined by the available variables in the datasets from which the study 
data were extracted. The use of retrospective secondary quantitative data whose quality at 
collection could not be guaranteed may have affected the study outcomes. Additionally, it 
was not possible to interrogate the data in depth because the interrogation was limited by 
the quantitative nature of the study.  
Significance, Summary and Conclusions 
Although it is two years since the National declaration on prioritization of cervical 
screening, little implementation has happened within the health care facilities in 
Swaziland. The Sexual Reproductive Health Unit with funding from Bristol Myers 
Squibbs Foundation developed an action plan to provide basic equipment to conduct the 
screening tests and train health care providers to use the equipment (Jolly et al., 2017). 
However, this funding has not yet translated into effective program implementation, there 
is no uniformity in level of provision of cervical cancer screening across the regions let 
alone within the same region and the outcomes of these activities are not yet evaluated 
especially among adolescent girls and young women who are a vulnerable population 
requiring strong prevention efforts (Church et al., 2015). These issues highlight the need 
for mainstreaming cervical cancer screening programs within the public health system.  
To curtail excessive expenditure on infrastructure and in view of the high HIV prevalence 
in this country (32%), cervical cancer screening services in this country should preferably 
be population based, systematic and integrated within primary care clinics and leveraging 
existing infrastructure for provision of screening (Church et al., 2015; Parham et al., 
2015). This literature review summarized some of the available evidence on the system 
barriers to cervical cancer screening among women and when available on AGYW to 
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provide a context for the analysis of the situation in Swaziland. I reviewed the available 
data to describe the health system determinants of cervical cancer screening among HIV 
infected AGYW whose treatment outcomes impact negatively on themselves, the HIV 
and Sexual and Reproductive Health Unit program performance and the communities 
within which they live. The results of the study may be used to inform public health 
programming within this population to improve cervical cancer screening and reduce 
both the morbidity and mortality associated with this cancer in this population.  
This study was important because it focused on cervical cancer screening among a 
high-risk population in Swaziland. Early detection of cervical cancer in this group will 
provide an opportunity for early treatment thereby reducing morbidity and premature 
mortality and associated elevated health care costs (Hung, Liu, Cheng, & Wang, 2014). I 
sought to identify gaps in the health care inputs that affect the uptake of cervical cancer 
screening. The contribution of this study to the current limited literature regarding 
cervical cancer screening in Swaziland was to provide additional evidence regarding the 
determinants of cervical cancer screening in high risk young women. The findings may 
generate additional questions that will form the basis for more research. The sexual 
reproductive health program of the Ministry of Health can use the findings to improve 
cervical screening services within the country. Public health practitioners can also use the 
significant findings to inform health promotion and education programs for both health 
care workers and clients, as well as policy guidelines to inform screening 
recommendations. 
Young women are the backbone of many communities in Swaziland as the men 
migrate looking for work and therefore are responsible for both social and economic 
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growth in their communities (Brixiová & Kangoye, 2016). If they are affected by cervical 
cancer for which there is limited treatment, communities will suffer as will the children 
and the elderly who these women take care of (Hajizadeh, Sia, Heymann, & Nandi, 
2014). This study could contribute to positive social change by responding to the 
Swaziland National Health Policy 2015-2020 goal to reduce the incidence of cancer 
deaths through improvements in the equitable and accessible delivery of health services 




Section 2: Research Design and Data Collection 
Introduction 
HIV-infected young Swazi women are at increased risk of cervical cancer because 
of their low participation in preventative screening programs and their HIV infection 
(Swaziland Ministry of Health, 2015c). Cervical cancer is a major contributor of 
morbidity and mortality among Swazi women and especially HIV-infected young women 
(Information Centre on HPV and Associated Cancers, 2016; Swaziland Ministry of 
Health, 2016). The purpose of this study was to examine the relationships between health 
care institutional factors and the uptake of cervical cancer screening among HIV-infected 
AGYW to inform policy and interventions to reduce morbidity and mortality related to 
this disease. In this section, I describe the research design and the rationale and the 
conduct of the research including data  
Research Design and Rationale 
The overall design of my study was a quantitative approach, as I used secondary 
data extracted from the Swaziland Ministry of Health’s HMIS to answer the research 
questions (see Creswell, 2014). I also used a correlational cross-sectional study design to 
explore the relationships between health care institutional factors and the uptake of 
cervical cancer screening among HIV-infected AGYW in Swaziland. A cross-sectional 
design was deemed appropriate because the intention of this research was to determine 
the empirical relationship between the independent and dependent variables and not 
determine causation (Sedgwick, 2014a). The study methods did not include the 
observation or interviewing of participants but rather the examination of routine data 
from surveys, making this study also retrospective in nature (Sedgwick, 2014b). The 
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factors that were investigated included the availability of cervical cancer screening 
services in clinics, the presence of trained health care providers, the availability of 
referral systems for screening, and the age of the women. Other covariates included 
location of the clinic and ownership of the clinic.  
Independent variables. The independent health care institutional factors that I 
investigated included: 
• The availability of cervical cancer screening services in a facility, that was 
defined as the facility having the infrastructure to conduct the screening, the 
mechanisms to obtain pathology results of the screening test, and the systems to 
feedback to the patient to trigger appropriate health seeking behaviors (WHO, 
2013) 
• The presence of trained health care workers within the facility that was defined as 
a health care worker who has undergone an accredited training on cervical cancer 
screening and is recognized by the Sexual and Reproductive Health Unit as being 
a trained provider  
• The provision of referrals for cervical cancer screening to eligible women, that 
encompassed a health care provider referring an eligible woman for cervical 
cancer screening and documenting the referral as well as the outcome of the 
referral in the patient record (Miller, Hanson, et al., 2014) 
• Although not an institutional factor, I also examined the difference in uptake of 
cervical cancer screening between HIV-infected adolescent girls and HIV-
infected young women.  
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Dependent variable. There was only one dependent variable for the study, that 
was the uptake of cervical cancer screening. This was defined as the acceptance, seeking 
out, and receipt of cervical cancer screening in an eligible woman or women (Mwaniki et 
al., 2014).  
Additional factors that were assessed included locality of the clinic (rural or 
urban) and ownership of the facility. These were categorized as government owned, 
missionary owned, private for profit, and private not for profit, as these may have played 
a role in the availability of the cancer screening services in a clinic.  
Rationale for Secondary Data Analysis 
Secondary data analysis is a valid research design that requires the rigor 
demanded of primary data analysis research designs, that consists of the researcher 
collecting, analyzing, and interpreting data (Johnston, 2014). Similarly, in secondary data 
analysis there are procedural and evaluative steps: the researcher is required to develop 
research questions, identify potential datasets, and then evaluate the dataset to ensure it 
can answer the research questions (Johnston, 2014; Koziol & Arthur, 2012). Fundamental 
to secondary data analysis is the application of theoretical knowledge and conceptual 
skills to use existing data to address the research questions (Cheng & Phillips, 2014). 
Advantages of secondary data analysis. The advantages associated with 
secondary analysis are the timeliness of production of results, cost effectiveness, and 
convenience it provides as minimal financial resources have to be allocated to the data 
collection processes (Johnston, 2014). The availability of quality secondary data allows 
researchers to access and use datasets that have larger sample populations that are more 
representative of the target population, that allows for more generalizable findings and 
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increased validity (Windle, 2010). Secondary data analysis also presents opportunities to 
conduct research and allows for building capacity for empirical research (Cheng & 
Phillips, 2014). Finally, using secondary data allows research studies to be completed 
quicker and results produced in a timely manner to inform policy and practice (Goodwin, 
2012).  
Disadvantages of secondary data analysis. Despite the advantages, there are 
disadvantages to using secondary data. The most common limitation is inherent to the use 
of secondary data in that the data were collected for another purpose and may not provide 
adequate or in-depth data that the researcher requires, limiting the location of study, the 
population, or even the variables (Schlomer & Copp, 2014). Another limitation is that the 
researcher using secondary data cannot guarantee the quality of the data that were 
collected. The researcher can review the data collection and validation processes but 
cannot correct the inadequacies of the data and therefore these will become inherent 
limitations or causes of bias to the secondary data analysis. 
Methodology 
Population 
The population that I studied were HIV-infected young women between the ages 
of 15 and 24 attending HIV care clinics in Swaziland. The young women were further 
disaggregated into adolescent girls aged 15–18 and young women 19–24. This population 
makes up 10.4% of the total population in Swaziland, that has the second highest HIV 
incidence rate of 1.87 and accounts for 14 % of the HIV-infected population in 
Swaziland. There were 185 HIV care and treatment clinics in the country, and there were 
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12,329 HIV-infected AGYW enrolled in care by the end of March 2018. The population 
under study was drawn from these HIV care clinics. 
Data Set 
I used routinely collected data for my study that was provided by the Ministry of 
Health’s HMIS unit that aggregates all facility level data at the national level. For this 
study, I used data from the HIV care clinics collected until March 2018, the training 
information management system, and the SARA 2017. The HMIS unit provided a 
semimerged set of data that included a listing of AGYW per facility and included a 
system generated unique identifier or serial number (this number is generated whenever 
the data is requested and is not a personal identification number), date of birth, treatment 
regimen, and referrals or future appointments for screening services as well as other care 
services clients receive such as tuberculosis screening and cervical cancer screening. The 
training information management system collects information on the type of training, the 
facilities that received the training and the number of nurses from each facility that were 
trained. A list was generated from the training information management system that 
provided each facility with number and cadre of provider who have been trained and 
certified to provide cervical cancer screening. The SARA 2017 is a comprehensive 
survey database that provided a listing of facilities that provide HIV care services to 
AGYW and their characteristics such as the presence of cervical cancer screening, 
location of the clinic, and ownership of the clinic.  
To achieve the data set I needed to answer my research questions, I merged the 
patient level dataset and the SARA dataset into one dataset. The common variable was 
the facility unique identifier. All routinely collected data undergoes validation during 
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quarterly routine data quality audits that are conducted by the HMIS unit. As per the 
national data management guidelines, all facilities are required to conduct data quality 
checks, prior to submitting their quarterly reports (HMIS, n.d.). These procedures ensured 
that the data that was collected and deposited within the HMIS unit meets a certain 
quality standard and therefore improved the validity of this study. 
The SARA 2017 data are available on the government website and required no 
specific permission to use. However, for the HIV care and treatment data and the health 
care provider training data, permission was sought from the HMIS unit. To be able to 
disseminate the research findings, I made a formal request to the National Health 
Research Review Board once the proposal was approved by Walden University. 
Sampling Procedures Used to Collect Data  
In the study, I employed total population sampling that is a type of purposive 
sampling (Laerd Dissertation, 2012; Wu Suen, Huang, & Lee, 2014). This is because the 
HIV-infected AGYW were a relatively small population in comparison to the rest of the 
people living with HIV attending HIV care clinics in Swaziland (only 14%). All facilities 
providing HIV care to the target population were included in the sample. There was no 
set number of AGYW in each health facility; therefore, all HIV-infected AGYW enrolled 
in these facilities were included in the study. The minimum sample size to adequately 
power the study was calculated to ensure that the number of AGYW in the data set met 
this minimum number and informed the interpretation of the results. The use of purposive 
sampling in my study affected the generalizability of the results (Parker, 2013). However, 
total population sampling ensured that all eligible AGYW in the target population were 
included in the study and enabled some analytical generalizations about the target 
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population (Laerd Dissertation, 2012). The disadvantage with total population sampling 
is that all people in the target group need to be included in the sampling frame and if they 
are not, an important characteristic may not be investigated (Parker, 2013).  
Sampling Frame  
A list of all health facilities that offer HIV care services in each of the regions in 
the country was obtained from the SARA 2017 and used as the sampling frame for the 
study. The health facilities were disaggregated according to level of care provided: 
primary health clinics, health centers, and regional or referral hospitals as well as the 
region in which they were located. To ensure completeness of the sampling frame, I 
consulted with the Swaziland National AIDS Program to confirm that all HIV care clinics 






Health Facilities in Swaziland that Provide HIV care by Region  
Region Primary Health Clinics Health Centers Hospitals 
Shiselweni 19 2 1 
Hhohho 48 2 4 
Manzini 66 0 4 
Lubombo 37 1 1 
Total 170 5 10 
 
Primary health clinics make up 92% of all health facilities that offer HIV care. 
Health centers make up 2.6% of all health facilities providing HIV care and treatment 
services. Because health centers offer more services than the primary health clinics and 
have at least one doctor available, they tend to have more patients, especially children 
and adolescents, than the primary health clinics. Hospitals account for only 5.4% of all 
health facilities in Swaziland; however, they were the first institutions to offer HIV care 
and also provide management of treatment experienced patients and the vulnerable 
populations under which the AGYW fall. Thus, the total number of facilities that provide 
the sample of AGYW were 170 primary health clinics, five health centers, and 10 
hospitals, making a total of 185 health facilities. 
Use of the sampling frame to obtain the sample size. Once all the HIV care 
clinics were verified by the National AIDS Program, data from these facilities were 
requested from the HMIS and the data pertaining to the target population of AGYW were 
extracted. Given that there was no set number of HIV infected AGYW per health facility 
and their distribution across the different types of health facilities was varied, all AGYW 
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in each facility were included in the sample population. The use of all AGYW in the 
sample population increased the generalization of the results. Because the sample size 
was predetermined, this affected the power of the study to detect significant differences 
between the independent and dependent variables. A power analysis requires an effect 
size that is usually determined after the data collection and analysis (Ryan, 2013).  
There is a lack of literature regarding institutional factors that impact on the 
uptake of cervical cancer screening among AGYW for me to have been able to reference 
an effect size to estimate the power of the study. Therefore, I conducted a post hoc power 
analysis to calculate the power and compared it with the one I estimated using an effect 
size value of 0.3 as it indicated a medium to large difference. I used the software 
G*Power 3.1.9.2 to compute the power analysis for sample size. I chose to use the χ² test 
because I wanted to examine the relationship between nominal level categorical variables 
(Simpson, 2015). The margin of error chosen for the study was 5% with a 95% level of 
confidence. The analysis was a priori to compute a minimum sample size and power of 
the study. The output is as follows: 
Input: Effect size w = 0.3 
α err prob = 0.05 
Power (1-β err prob) = 0.95 
Df = 1 
Output: Non-centrality parameter λ = 13.0500000 
Critical χ² = 3.8414588 
Total sample size = 145 
Actual power = 0.9507851 
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Based on this computation, a minimum sample size of 145 AGYW was required to 
achieve at least 95% chance of being able to detect a 30% effect size of the relationship 
between the independent and dependent variables.  
I conducted the post hoc power analysis for a one sample study with a 
dichotomous end point using the uptake of cervical cancer screening among the 
population of 33%, the uptake of cervical cancer screening among the study population of 
20.45%, the study population of 10,618 and an alpha level of 0.05 resulting in a post-hoc 
power of 100%. Figure 1 illustrates the calculation for the post-hoc power analysis. 
 
Figure 1: Post hoc Power analysis 
  
Inclusion and Exclusion Criteria 
All health facilities providing HIV care services were eligible to be included in 
this study. HIV care clinics that did not have any HIV infected AGYW enrolled in care 
were excluded from the analysis. Facilities with HIV care clinics that had not submitted 
quarterly data reports to the HMIS consistently over the two years 2016-2017 were also 
excluded because their data were incomplete. This exclusion criteria were included to 
ensure that only recent and updated data were used in the study.  
50 
 
The inclusion criteria for the study population were the AGYW aged between 15 
and 24 years who have been diagnosed HIV positive and enrolled in HIV care. These 
AGYW should have been in care for at least two years to allow enough time within the 
clinic for the AGYW to receive at least one cervical cancer screening. All HIV positive 
AGYW who had been enrolled in the HIV clinic less than one year were excluded from 
the study.  
Instrumentation and Operationalization of Constructs 
The measuring instrument I used was in the form of a questionnaire. The 
questionnaire was a set of structured questions that was used to obtain and aggregate the 
data from the secondary dataset to answer the research questions without the need to 
interview the target population (Timmins, 2015). I selected the questionnaire method as 
the data collecting methodology because it made the quantification of information 
possible (Aitrs, 2012). Questionnaires can be used to diagnose institutional functioning 
(Liamputtong, 2013); however, the construction of a questionnaire is complex because 
every question or item must be formulated carefully based on the research questions 
(Rowley, 2014). The questionnaire can be extracted from service standards or guidance 
documents for consistency and validity (Govender, Mabuza, Ogunbanjo, & Mash, 2014). 
The questions that I used to interrogate the availability of cervical cancer screening 
services was informed by the WHO guidance on Cervical Cancer Screening programs 
(WHO, 2013). Other researchers who have conducted studies that investigated the 
systemic factors affecting uptake of cervical cancer screening have used the WHO 
guidance on Cervical Cancer Screening Programs as the basis for the development of 
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their tools (Akinyemiju, McDonald, & Lantz, 2015; Campos et al., 2015; R. 
Sankaranarayanan, 2014).  






Definitions of Variables  
Research 
Question  
Variable Data Source Definition Measurement 
Facility 
characteristics  
Facility type Service 
Availability 
Mapping 
There are three 
categories depending on 
services provided: 
Primary Health Clinic, 
Health Centre, or 
Hospital 
Categorical: single 







Classification of location 
of the facility as either 
rural or urban 
Categorical with two 
options - single 
response out of two 
options that include 
rural location of clinic 







Number that is assigned 
to the facility by the 
ministry 
Categorical because 







Facility can be owned by 
private, government or 
mission entities 
Categorical: single 









Facility meets the 
criteria for providing 
cervical cancer screening 
services including 
equipment to conduct 
screening, in-service 
communication and 
mechanism to examine 
samples and provide 
results to the clients 
Nominal: Yes, facility 
has cervical cancer 
services or No, facility 
does not have cervical 
cancer screening 
services 






Number of days per 
week that cervical cancer 
screening is offered 
Categorical: single 
response out of three 
options. The number 
of times services are 
provided will be 









Signage at the facility 
that advertises cervical 
cancer screening services 
Nominal: the response 
is either a yes, services 
are advertised or no, 












birth/age at last 
birthday 
HMIS Date of birth recorded 
in register of AGYW 





HMIS Date that AGYW was 
registered for HIV care 
Categorical (date): the 
date will be used to 
calculate number of 
years that the client has 




has been in HIV 
care 
HMIS Length of time that the 
AGYW has been 




HMIS Date that AGYW was 
started on HIV 
treatment 
Categorical (date): the 
date will be used to 
calculate number of 
years that the client has 
been on HIV treatment 
Number of 
years AGYW 
has been on 
HIV treatment 
HMIS Length of time in years 
that AGYW has been 





HMIS AGYW has been 
diagnosed with HIV at 
least 12 months and 
should receive a 
cervical cancer 
screening as per HIV 
management guidelines 
Categorical: the 
responses include either 
yes, eligible for 
screening or no, not 




HMIS AGYW has undergone 
cervical cancer 
screening in the last 12 
months. 
Categorical: the 
responses include either 
yes, has received 
cervical cancer 
screening or no, has not 









within the last 
12 months 
HMIS Proportion of eligible 
AGYW that received a 
cervical cancer screen 
during 2016 - 2017  
Proportion or 
percentage of AGYW 
who were eligible for 
screening and then 




HMIS Results of the screening 
available in the register 
Nominal: either 
responds as yes, 
screening results are 
documented or no, 
screening results not 
documented 
(table continues) 





What is the relationship 
between the availability 
of trained health 
providers and the 
uptake of cervical 
cancer screening among 
HIV-positive 
adolescent girls and 












The facility has 





Nominal: response is 
either yes, trained 
providers are available 









Count of trained 
providers per 
facility 
Continuous (number of 
trainers) 
What is the relationship 
between the availability 
of cervical cancer 
screening services in a 
facility and the uptake 
of cervical cancer 
screening among HIV-
positive adolescent girls 





















and provide results 
to the clients 
Nominal: Yes, facility 
has cervical cancer 
services or No, facility 









Number of days per 
week that cervical 
cancer screening is 
offered 
Categorical: single 
response out of three 
options. The number of 
times services are 
provided will be 















Nominal: the response 
is either a yes, services 
are advertised or no, 


















Research Question  Variable Data 
Source 
Definition Measurement 
What is the relationship 
between the provision 
of a referral for cervical 
cancer screening among 
eligible women and the 
uptake of cervical 
cancer screening among 
HIV-positive 
adolescent girls and 




HMIS Patient provided 
with referral for next 
service is 
documented in the 
register/EMR 
Nominal: Yes patient 
was provided a referral 
or No patient was not 






HMIS If referral is 
documented, was it 
appropriate as 
determined by the 
need of the client.  
Nominal: Yes 




Is there a difference in 
uptake of cervical 
cancer screening 
between HIV-positive 














eligible AGYW who 
received a cervical 
cancer screen during 




Age group to 
differentiate 





will be grouped into 
15 to 19 years old 
and 20 - 24 years 
Categorical 
 
Data Analysis Plan 
The data analysis plan articulates how the data were cleaned, transformed, and 
analyzed (Banks, Paige, & Mather, 2013; Michener, 2015).  The data analysis plan is a 
roadmap for how the data were managed and the data analysis conducted. SPSS v25 was 
used to conduct the data analysis. 
Cleaning the Data  
Data cleaning is the removal of outliers, dealing with missing data and assessing 
for normality to determine the need for data transformations (Chu, Ilyas, Krishnan, & 
Wang, 2016).   
Outliers. All the variables measured on a continuous scale like age, length of 
time the AGYW has been in HIV care and length of time the AGYW has been on HIV 
treatment was assessed for outliers. If an observation had a standard deviation of greater 
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than ±3.29 from the variable’s mean, it was considered as an outlier (Aguinis, 
Gottfredson, & Joo, 2013). This was accomplished by standardizing the scores of the 
variable (the variable’s scores have a mean of zero and a standard deviation of 1) and 
looking for an observation greater than ±3.29 (Aguinis et al., 2013). 
Missing data. Missing data is the absence of an observation on a variable. 
Handling missing data may be especially challenging when using secondary datasets and 
is necessary to reduce bias and enable the valid deduction of results (Palmer & Royall, 
2010). Missing data may threaten statistical power by reducing sample size or, in more 
extreme situations, estimates derived by deleting cases with missing values may be 
biased, particularly if the cases with missing values are systematically different from 
those with complete data (Kaiser, 2014). There are many ways to deal with missing data 
and the selection of an appropriate remedy is determined by the percentage of missing 
data and the importance of the variable in the study (Dohoo, 2015; Groenwold, Donders, 
Roes, Harrell, & Moons, 2012). When missing data is less than 10%, it is acceptable to 
drop the observation, however, if larger proportions are missing, the re-weighting of the 
variable or multiple imputation are more appropriate choices (Osborne, 2013). Using 
SPSS, I generated frequency tables for all the variables to determine the proportions of 
missing data. If the missing data were less than 10%, the events would have been 
dropped if determined not to adversely affect the results of the study by running the 
statistical tests with and without the missing data (Dong & Peng, 2013; Howell, 2015). 
However, there were no missing data.  
Normality. Majority of the parametric tests have the assumption of Normality. 
Normality refers to the shape of the distribution of scores (e.g., shape of a normal bell 
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curve) (Ghasemi & Zahediasl, 2012). I assessed for normality by examining the skewness 
and kurtosis of each continuous variable (age and length of time on treatment) using 
SPSS. The data approximated the normal distribution, and no further manipulation was 
done. However, had the data not been normally distributed, a transformation of the data 
may have been required.  Some common transformations are the square root, logarithmic, 
and inverse. 
Specific Statistical Tests to Examine Each of the Research Questions 
The research questions enabled the description of the relationship between the 
selected health care institutional factors and the uptake of cervical cancer screening 
among the target population. 
Research Question 1: What is the relationship between the availability of trained 
health providers and the uptake of cervical cancer screening among HIV-positive 
adolescent girls and young women in Swaziland?  
H01: There is no relationship between the availability of trained health care 
providers and the rate of uptake of cervical cancer screening among HIV-positive 
adolescent girls and young women.   
Ha1: There is a relationship between the availability of trained health care 
providers and the uptake of cervical cancer screening among HIV-positive adolescent 
girls and young women.   
Research Question 2: What is the relationship between the availability of cervical 
cancer screening services in a facility and the uptake of cervical cancer screening among 
HIV-positive adolescent girls and young women in Swaziland? 
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H02: There is no relationship between the availability of cancer screening services 
within a facility and the uptake of cervical cancer screening.  
Ha2: There is a relationship between the availability of cervical cancer screening 
services within a facility and the uptake of cervical cancer screening.  
Research Question 3: What is the relationship between the provision of a referral 
for cervical cancer screening among eligible HIV positive adolescent girls and young 
women and the uptake of cervical cancer screening among HIV-positive adolescent girls 
and young women in Swaziland? 
H03: There is no relationship between the provision of a referral for cervical 
cancer screening in eligible women and the uptake of cervical cancer screening. 
Ha3: There is a relationship between the provision of a referral for cervical cancer 
screening in eligible women and the uptake of cervical cancer screening. 
Research Question 4: Is there a difference in uptake of cervical cancer screening 
between HIV-positive adolescent girls and HIV-positive young women? 
H04: There is no difference in uptake of cervical cancer screening between HIV-
positive adolescent girls and HIV-positive young women. 
Ha4: There is a difference in uptake of cervical cancer screening between HIV-
positive adolescent girls and HIV-positive young women. 
Data Analysis 
The selection of the statistical analysis is based on two things: the way the 
hypothesis is stated in statistical language and the level of measurement of the variables 
(Karran, Moodie, & Wallace, 2015). To examine the research questions, that were 
examining the relationship between independent variables and a dichotomous outcome, a 
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chi-square analysis was conducted.  For ordinal level variables, the Cochran-Armitage 
test of trend was performed (Wellek & Ziegler, 2012). 
When examining the influence of one variable on another and the dependent 
variable is dichotomous, then a logistic regression is the appropriate test to use, if there 
are more than one categorical independent variables and the dependent variable is also 
categorical, the appropriate test to use is a bivariate logistic regression and the linear 
regression is the correct analysis if the dependent variable is interval level (Kasza & 
Wolfe, 2014). 
Univariable analysis.  An analysis was conducted to describe the characteristics 
of the population as well as determine the frequency of the outcome. The characteristics 
of the population were described by person, and place and illustrated as frequencies. 
Stratified frequencies were calculated across the age sub-groups. Further analysis was 
conducted to describe the frequency distribution of the outcome variable and a 
confidence interval for the prevalence estimate. Frequencies were used to describe the 
categorical data and histograms were used to visualize the continuous variables 
(Humphrey, Taylor, & Mittag, 2014; Weissgerber, Milic, Winham, & Garovic, 2015). 
Bivariable analysis. Data to answer each of the research questions were 
displayed in two variable tables. Two variable tables were used to determine whether 
uptake of cervical cancer screening varied by age group. Two variable tables were also 
used to quantify the associations between the independent variables and the outcome 
variable with the rows representing the different levels of exposure and the columns 
representing absence or presence of the outcomes. 
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Calculating Measures of association. Measures of association were computed 
and interpreted for the associations between the independent variables and the outcome.  
Calculating Statistical Significance. Given that my research questions were 
testing the relationship of the independent variable that was categorical to the dependent 
variable that had a dichotomous outcome, I used a Chi Square analysis. The chi-square is 
an appropriate statistical test when the purpose of the research is to examine the 
relationship between two nominal level categorical variables (Mchugh, 2013). I 
compared the calculated chi-square coefficient (χ2) and the critical value coefficient to 
evaluate the significance of the results.  When the calculated value was larger than the 
critical value, with alpha of .050, the null hypothesis was rejected (suggesting a 
significant relationship) (Sharpe, 2015).  The alpha value also known as the significance 
level is the probability of rejecting the null hypothesis when the null hypothesis is 
actually true (Krzywinski & Altman, 2013). The alpha value for this study was set at 0.05 
or a five percent probability of rejecting the null hypothesis when it is true. In order to 
determine the degrees of freedom for a chi-square, it was necessary to use the following 
equation: 
df = (r – 1)(c – 1) 
The r value equals the number of rows, and the c value equals the number of 
columns.  In order for a chi-square to run correctly, several conditions and assumptions 
must be met: the data must be random samples of multinomial mutually exclusive 
distribution and the expected frequencies should not be too small (Mchugh, 2013).  As a 
precautionary measure in chi-square examination, the expected frequencies below five 
should not account for more than 20% of the cells, and there should be no cells with an 
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expected frequency of less than one.  If the expected cell frequencies were less than 5, 
Yates continuity correction or Fisher’s exact test was used to test for significance (if it is 
a 2x2 chi square), as it is a more conservative statistic (Connelly, 2016). For the ordinal 
level variables, a Cochran-Armitage test of trend was conducted and to compare two 
proportions, the test of two proportions was conducted (Wellek & Ziegler, 2012). The 
Cochran-Armitage test of trend otherwise known as the Chi Square test of trend was used 
to assess for the presence of an association between a binomial outcome variable with an 
independent ordinal variable with K categories, where K is any number more than two 
(Zhou, Ku, Huang, Xing, & Xing, 2017).   
Assessing for effect measure modification. An effect size or effects measure was 
calculated for all significant tests. The Effect size is a simple way of quantifying the 
difference between two groups (Fritz, Morris, & Richler, 2012; G. M. Sullivan & Feinn, 
2012). It emphasizes the size of the difference and how it relates to the general 
population. It suggests the clinical or “real world” relevance of the findings of the 
research. Usually, the effect size is agreed upon a priori so that a sample size can be 
calculated to adequately power the study. Phi φ is a measure of effect size and is 
equivalent to the correlation coefficient r (Bosco, Aguinis, Singh, Field, & Pierce, 2015; 
Kelley & Preacher, 2012). It is used when the variables are categorical. Phi is defined by 
the formula: 
 
where n = the number of observations. A value of .1 is considered a small effect, .3 a 
medium effect and .5 a large effect (Lakens, 2013). 
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Assessing the effect of potential confounders. Confounding is an apparent 
association between the population and the outcome in this case the uptake of cervical 
cancer screening that results from a third factor that has not been considered in the 
relationship (Creswell, 2014). A confounder is an independent risk factor for the outcome 
and also happens to be associated with the independent variable or variables under 
investigation. 
Conducting multivariable analysis. A multivariable analysis and modeling 
technique was conducted to address the hypotheses in the research questions. The results 
from the bivariable analysis informed the modeling technique to determine the final 
model or set of models that best described the data, as all statistically significant 
relationships needed to be included in the model (Connolly, 2011; Soley-Bori, 2013)., I 
used multivariable logistic regression to examine the relationship between the dependent 
variable that had a dichotomous outcome and the independent or predictor variables. The 
multivariable regression analysis model helped me understand how the typical value of 
the dependent variable (uptake of cervical cancer screening) changes when any one of the 
independent variables is varied (for example or presence of diagnostics), while the other 
independent variables are static. The dependent variable in my study was the uptake of 
cervical cancer screening and the independent variables included the presence of trained 
providers, availability of cervical cancer screening services within an HIV clinic, 
provision of a referral for appropriate services, and age group of the client. The 
multivariable logistic regression allowed me to predict values of the dependent / outcome 
variable for a specific independent variable as well as suggesting which independent 
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variables had a major effect on the dependent/ outcome variable. (Sperandei, 2014). In 
research question 1, the outcome variable was uptake of cervical cancer screening while 
the predictor variable was trained health care providers whose impact on uptake was 
assessed in the presence of other factors such as age group availability of referral 
services, and availability of cervical cancer screening services. In research question 2, the 
outcome variable was uptake of cervical cancer screening while the predictor variable 
was the availability of cervical cancer screening services in facilities whose impact on the 
uptake was assessed in the presence of availability of trained health care providers, age 
group and availability of referral services. In research question 3, the outcome variable 
was the uptake of cervical cancer screening services while the predictor variable was the 
availability of referral services whose impact on uptake was assessed in the presence of 
trained health care providers, age group and availability of cervical cancer screening 
services in facilities. In research question 4, the outcome variable was the uptake of 
cervical screening while the predictor variable was age group whose impact on uptake 
was assessed in the presence of other factors such as trained health care providers, 
availability of cervical cancer screening services and availability of referral systems. 
Other confounding variables that were put into each of these models included the location 
of the facility, facility ownership, and mean length of time the AGYW has been on 
antiretroviral therapy. In the analysis, the data were examined to see if it meets the 
assumptions of normal distribution, absence of multicollinearity, homoscedasticity, 
independence of observations, and linearity between the dependent and independent 
variables, prior to running the multivariable analysis.   
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Threats to Validity 
External Validity 
In quantitative research, external validity is important because as researchers, the 
conclusions we make from our studies should ideally be applicable to a wider population 
than the sample we studied (Matt, Brewer, & Sklar, 2010). These results can ideally be 
generalized to a larger population from which the sample was obtained or can be 
generalized to other populations or settings or time frames. External validity asks the 
question: To what extent can our conclusions be generalized to a wider population. No 
study can be completely externally valid. To assess the extent to which generalizations 
can be made, we have to determine how well the study sample represents the wider 
population (Polit & Beck, 2010; Yin, 2013). The extent to which study results 
are robust across different populations and settings varies according to the research 
paradigm (i.e., a positivist versus a post-positivist research paradigm). Positivists tend to 
build grander theories and therefore make broader generalizations from the results while 
Post-Positivists are less likely to have expansionist theories and make conservative 
generalizations. The various research designs (descriptive, quasi-experimental, 
experimental) also affect the external validity of the study conclusions (Banerjee, 
Chassang, & Snowberg, 2016).   
Threats to external validity are any factors within a study that reduce the 
generalizability of the results of which there are a wide range including (a) selection 
bias; (b) threats due to the constructs, methods and confounding that has not been 




Selection bias. People differ along a wide range of factors that are inherent to the 
person, such as age, gender, height, intelligence, attitude, behavior. When the sample that 
is studied does not represent the population from which the sample was selected, there 
has been a selection bias (Pearce & Richiardi, 2014; Westreich, 2012). Where selection 
bias occurs, it is challenging to argue that the results can be generalized to the wider 
population. In experimental research designs, selection bias can be reduced through 
the random selection and assignment of participants (Etikan, 2017). Random assignment 
ensures that the participants are randomly allocated to a group and are comparable across 
a range of general and specific characteristics including age and gender (Etikan, 2017). 
Selection bias is more likely to occur in research designs that do not randomly select or 
assign participants such as in quasi-experimental research like observational cohort 
studies or when purposive sampling is used, and this is a threat to the external validity of 
these types of studies (Pearce & Richiardi, 2014). Despite adequate selection techniques, 
the generalizability of the study results may be affected by extraneous variables that 
relate to the characteristics of the sample such as attitude, personality, culture over which 
the researcher has no control and these act as confounders (Kamangar, 2012; Sullivan, 
2016). The uptake of cervical cancer screening is not only dependent on institutional 
factors but also on the attitude, knowledge and perceptions of the women who are eligible 
for cervical cancer screening (Dulla et al., 2017; Ndejjo et al., 2016). This quantitative 
study did not investigate these variables and therefore these will affect how the results are 
interpreted.   
Generalization and constructs. The operationalization of the study (how the 
constructs, variables and interventions are defined) will affect whether the results from 
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the study can be generalized to a wider population.  In quantitative research designs, 
broad concepts should be narrowed into constructs that can be measured. Constructs are 
the building blocks of theories, that help to explain how and why certain phenomena 
behave the way that they do. In assessing the determinants of cervical cancer screening 
among HIV infected young women, the theory that was utilized was a systems theory and 
one of the constructs was service availability that had many parameters. However, in this 
study, to measure the construct of service availability, presence of advertised services, 
presence of infrastructure, and presence of results delivery systems were some of the 
variables that were used to quantify the service availability; the use of multiple variables 
to measure a single construct reduces the risk of mono-operation bias, a threat to 
construct validity and therefore external validity. Because this was a limited view of 
service availability, I could only generalize across the construct and generalizations 
across the selected variables to measure service availability within the boundaries of the 
operational definition that I provided for the construct of service availability and the 
measurement variables. 
Internal Validity 
Confounding and extraneous variables. Confounding variables or confounders 
are those variables that can provide an alternative explanation for the results if they are 
present and are inherent characteristics in a study subject that the researcher cannot 
modify or remove, these include, age, sex, socioeconomic status, religion, education level 
(Kamangar, 2012). If these variables are not being studied, then they are also known as 
extraneous variables (Kamangar, 2012). Both confounding and extraneous variables can 
threaten the internal validity of the results. In experimental research design, these 
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extraneous variables can be controlled for by for instance case controlling and therefore 
reduce the confounding effect ( Sullivan, 2016). In my study that was not case controlled, 
the potential for confounding and extraneous variables was high and a consideration of 
testing of influence on the dependent variable by specific confounding variables such as 
location of the clinic and the ownership of the clinic was made.  
Ethical Procedures 
In secondary data analysis, the original data were not collected to answer the 
present research question. My research used secondary data that were routinely collected 
at facilities and aggregated at the Ministry of Health HMIS Unit. I used data collected by 
the HMIS until March 2018 and provided a list of variables to inform the dataset 
requested from the SIU. I sought permission from the Ministry of Health to obtain 
deidentified facility level data. De-identified or anonymized information promotes 
privacy and prevents breach of patient confidentiality policies (Fullerton & Lee, 2011). 
Only data that pertained to HIV infected AGYW from the HIV care facilities were 
requested to prevent unnecessary data collection (Brakewood & Poldrack, 2013). The 
SIU de-identified all data that was shared and because I used a specific population within 
each facility population, all attempts were made to ensure that individual patients could 
not be identified by removing all patient identifying numbers and addresses. Because 
there were no direct interactions with the target population, no consent was sought from 
them (Wilkinson et al., 2016). Some of the data such as SARA requires no prior 
permission and is available on the government website and therefore consent to use it was 
implied. However, the HMIS unit provided me with a complete dataset including all the 
data extracted from the SARA. All the data was obtained electronically and was stored on 
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password protected external hard drives. The files were encrypted to prevent accidental 
exposure of the data. There were no hard copies of the data and therefore there was no 
need for a locked cabinet designated for data storage. Only the statistician and I had 
access to the data.  All data will be kept in accordance with the Walden Institutional 
Review Board (IRB) which is five years. In addition to the University’s IRB (number 08-
06-18-0665327), I obtained permission from the Ministry of Health Research Review 
Board (number SRH027/2018) to publish and disseminate the results of the research.  
Summary 
My research set out to investigate the institutional factors that affected the uptake 
of cervical screening among HIV-positive young women who were disaggregated into 
adolescent girls aged 15 – 18 years and young women aged 19 – 24 years. The factors 
that were investigated were: the availability of cervical cancer screening services, the 
presence of trained health care providers, provision of referral for services and 
differences in uptake of screening by age. This was a quantitative cross-sectional 
descriptive research design using secondary data. The secondary data included routinely 
collected patient level data and survey data, all of which were housed at the Swaziland 
Ministry of Health Strategic Information Unit. Bi-variate analysis was used to examine 
the relationships between the institutional factors and the uptake of cervical screening. 
Logistic regression was used to determine the influence of one or multiple variables on 
each other and the dependent variable. All data were described using frequency tables or 
histograms as appropriate. The potential limitations of this research included: the use of 
secondary data and therefore not all parameters of cervical cancer screening were 
interrogated and not all confounding variables could be controlled for thereby impacting 
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on internal validity; it was a cross-sectional study and therefore causation could not be 
determined; no patient perspective was collected and analyzed and this limited the depth 
of the research, and this study was only conducted among HIV-positive young women 
whose demographics may be different from HIV-negative young women thus limiting the 
generalizability of the results. Ethical considerations in this study included the use of de-
identified data, all data were encrypted and only shared with the statistician who assisted 
with the statistical analysis. Approvals for data use and dissemination of results were 
sought from both Swaziland Ministry of Health Strategic Information Unit and the 
Walden University IRB and obtained prior to the start of the study. 
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Section 3: Presentation of Results and Findings 
Introduction 
In this quantitative retrospective study using secondary data, I sought to test the 
relationships between health system factors that predict the uptake of cervical cancer 
screening among HIV-infected AGYW aged 15 to 24 in Swaziland.  
Data Collection  
Secondary data from the 2017 Swaziland SARA that included HIV care and 
treatment and cervical cancer services variables and routinely collected data in the HMIS 
were used in this study. The SARA survey is a comprehensive health facility-based 
assessment tool used to appraise the availability of health services based on a standard set 
of indicators and health facility readiness to implement services (WHO, 2016). The 
SARA survey data were collected between May and October 2017. Following conditional 
Walden University IRB approval (number 08-06-18-0665327) on August 6, 2018, I 
submitted a data request to the Swaziland HMIS to provide the two datasets: SARA and 
routinely collected patient information. I received approval from the HIMS on September 
9, 2018 (SRH027/2018) and on September 12, 2018, received full approval from the 
Walden IRB to conduct my study. The HMIS provided deidentified data based on the 
data request form in two datasets—facility and training information in one dataset and 
patient level information in the other dataset. The HMIS did not have available data on 
referrals for cervical cancer screening for eligible AGYW and instead provided data on 
referrals for AGYW who had a positive visual inspection with acetic acid screen. 
Additionally, there were no data available on the outcomes of the referrals. The study 
population was HIV-positive AGYW 15 to 24 enrolled in HIV care and treatment. All 
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AGYW in the HIV care facilities that provided cervical cancer screening were included 
in the dataset and therefore the sample was considered representative of the population.  
IBM SPSS version 25 was used for data analysis. Descriptive analysis included 
frequencies for categorical data and mean and median for continuous data. Correlation 
analysis was used to analyze relationships between variables and included Chi-Square, 
the Cochran Armitage test of trend, and the test of two proportions. Binomial logistic 
regression analysis was used to test the predictive model of all significant variables. The 
level of statistical significance accepted for all tests was p = .05. The dependent variable 
for this study was uptake of cervical cancer screening. The specific health systems factors 
evaluated included presence of trained health care providers, presence of cervical cancer 
screening infrastructure, provision of referrals as well as differences in uptake between 
age groups. These were the predictor variables in the study.  
Descriptive Statistics 
Health Facilities 
There are 330 health facilities across the four regions in Swaziland. One hundred 
and eighty-five (56.1%) offer HIV care and/or HIV treatment services. Of these 185 
facilities, 110 (59.46%) offer cervical cancer screening. Apart from the Shiselweni region 
(20, 18.2%), Hhohho (29, 26.4%), Manzini (32, 29.1%), and Lubombo (29, 26.4%) had 
similar numbers of facilities providing cervical cancer screening. Most of the facilities 
(66, 60%) were in rural areas. The distribution of facilities offering cervical cancer 




Figure 2. Distribution of types of facilities offering cervical cancer screening services. 
The health facilities in Swaziland are classified as either government, 
mission/nongovernment organizations, industries, or privately owned. Government owns 
the most facilities (60, 54.5%) followed by mission/nongovernment organizations (25, 
22.7%), private (21, 19.1%) and then industries (4, 3.6%). Table 3 provides a summary of 




Table 3  
 
Distribution of Facilities that Offer Cervical Cancer Screening by Type, Ownership, and 
Location  
  Facility ownership 
Total 
  Government Mission/NGO Industry Private 
Rural 
Hospital 1 1 0 0 2 
Health center 4 0 0 0 4 
Public health unit 2 1 0 0 3 
Clinic with maternity 5 3 0 0 8 
Clinic without maternity 34 12 1 2 49 
Urban  
Hospital 4 1 1 3 9 
Health center 1 0 0 0 1 
Public health unit 5 0 0 0 5 
Clinic without maternity 4 7 2 16 29 
Note. NGO = nongovernment organization 
Adolescent Girls and Young Women 
There were 12,329 AGYW enrolled in 118 (69.2%) of the 185 HIV care facilities 
by the end of March 2018. Based on the eligibility criteria, 1,711 AGYW were in care for 
less than 1 year and were excluded from the study. A total of 10,618 AGYW were 
included in the study: 9,956 AGYW were in 81 facilities that provide cervical cancer 
screening, and 662 AGYW were in 37 facilities that do not provide cervical cancer 




Figure 3. Study participant flow. 
 
The mean age of the 10,618 AGYW was 20.96 (SD 2.734). Two thousand one 
hundred and nineteen AGYW (2,119, 20%) were between the ages of 15 to 18 years and 
their mean age was 16.62, whereas 8,499 AGYW (80%) were between the ages of 19 to 
24 and their mean age was 22.1. Of the 10,618 AGYW, 575 (5.9%) were not on 
antiretroviral therapy and 10,043 (94.1%) were on antiretroviral therapy. Of those on 
antiretroviral therapy, the mean length of time on treatment was 3.83 years (SD 3.37) 
with a minimum of 1 year and a maximum of 17 years. The group of AGYW who were 
not on treatment were not assessed for length of time in care as the current data systems 
do not capture date of enrollment into care.  
The majority of AGYW are found in the hospitals (5,749, 54.14%) followed by 
the clinics without maternity (2,467, 23.23%). The least numbers of AGYW were found 
in the clinics with maternity (262, 2.47%) and the public health units (526, 4.95%). This 
distribution pattern did not differ by age group. However, in the pre-antiretroviral therapy 
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group, there were no AGYW enrolled in care in either the public health units or in clinics 
with maternity services. See Table 4. 
Table 4 
 
Distribution of Adolescent Girls and Young Women in Facilities by Age and Treatment 
Status 
  Facility type 
Total 









15 - 18 1,177 443 26 61 421 2,128 
19 - 24 4,126 1107 500 201 1981 7,924 
Pre-ART 
15 - 18  76 9 0 0 6 91 
19 - 24  370 55 0 0 59 484 
Note. ART = antiretroviral therapy 
Urban facilities had more AGYW enrolled in HIV care than did rural facilities: 5,670 
(53.39%) compared to 4,948 (46.61%). Table 5 summarizes the distribution of the 
AGYW by age group and facility location. 
Table 5 
 
Distribution of Adolescent Girls and Young Women by Age and Facility Location 
 
Location 
Total Rural Urban 
 Age group 15 - 18  1,131 1,088 2,219 





Cochran-Armitage test of trend, Chi-Square test, test of two proportions, and 
binomial logistic regression were used as the inferential analysis to test the relationships 
between the dependent and the independent variables. 
Association Between Trained Health Care Providers and Cervical Cancer Screening  
Trained health care providers are one of the determinants for cervical cancer 
screening (Choma & Mckeever, 2015; Rosser, Hamisi, Njoroge, & Huchko, 2015). 
Multiple SARAs that have been conducted for cervical cancer show that the availability 
of trained health care providers improve the uptake of cervical cancer screening among 
women attending health care facilities (O’Neill, Takane, Sheffel, Abou-Zahr, & Boerma, 
2013; WHO, 2016). I sought to determine whether there was a linear association between 
the number of trained staff available and the number of AGYW who received cervical 
cancer screening. The research question and hypotheses were: 
Research Question 1: What is the relationship between the availability of trained 
health providers and the uptake of cervical cancer screening among HIV-positive 
adolescent girls and young women in Swaziland?  
H01: There is no relationship between the availability of trained health care 
providers and the rate of uptake of cervical cancer screening among HIV-positive 
adolescent girls and young women.   
Ha1: There is a relationship between the availability of trained health care 
providers and the uptake of cervical cancer screening among HIV-positive adolescent 
girls and young women.   
77 
 
The mean number of staff available for cervical cancer screening per facility was 
3.19 (SD 4.21, 0-22). Most of the facilities (70, 63.6%) had one to two staff available to 
conduct cervical cancer screening, whereas five facilities that offer cervical cancer 
screening had no staff available. The hospitals reported the highest number of staff (11+ 
staff) available for cervical cancer screening followed by the public health units (six to 10 
staff). See Table 6.  
Table 6 
 
Number of Trained Staff to Conduct Cervical Cancer Screening by Facility Type 
 
Staff available 
Total 0 1 - 2 3 - 5 6 - 10 11+ 
 Hospital 0 2 2 1 6 11 
Health center 0 1 3 1 0 5 
Public health unit 0 2 1 5 0 8 
Clinic with maternity 0 8 0 0 0 8 
Clinic without maternity 5 57 12 4 0 78 
Total 5 70 18 11 6 110 
 
The majority of the facilities (97, 88.2%) offering cervical cancer screening had 
staff who have been trained on cervical cancer screening in the last 2 years; 57 (58.8%), 
are in rural localities, and 40 (41.2%) are in urban localities. All hospitals (11) and health 
centers (five) had staff who have been trained in last 2 years, whereas 87.5% of the staff 
in public health units (seven out of eight) and clinics with maternity (seven out of eight) 
and 85.9% of staff in clinics without maternity (67 out of 78) had received training in the 
last 2 years.  
The Cochran-Armitage test of trend was used to determine whether there was a 
linear association between number of trained staff and uptake of cervical cancer 
screening because the number of trained staff was an ordinal independent variable and 
78 
 
the uptake of cervical cancer screening was a dichotomous dependent variable (see 
Bianchi et al., 2012; Wellek & Ziegler, 2012). The grouping of trained staff was 
considered ordinal as the grouping was zero staff, one to two staff, three to five staff, six 
to 10 staff and 11 or more staff. The assumptions to conduct the Cochran-Armitage test 
of trend included the presence of an ordinal independent variable, the dependent variable 
must be dichotomous, and that there ia a linear relationship/association between the two 
variables but not whether the trend is linear. The limitation of this test is that it does not 
test for curvilinear components. These assumptions were met by the study.  
The proportion of AGYW who received cervical cancer screening was per 
grouping of staff available in the facilities were one to two staff (0.176), three to five staff 
(0.172), six to 10 staff (0.358), and 11 or more staff (0.216). See Table 7.  
Table 7 
 
Adolescent Girls and Young Women Who Received Screening and Number of Trained 
Staff Available  
    Trained staff 
Screened 1 - 2 3 - 5 6 - 10 11+ 
Yes 
 N 353 548 373 803 
% AGYW screened 
within Trained staff 17.60% 17.20% 35.80% 21.60% 
No 
N 1655 2540 669 2915 
% AGYW not 
screened within 
Trained staff 
82.40% 82.80% 64.20% 78.40% 
  Total 2008 3188 1042 3718 
  
% AGYW per 
trained staff 
grouping 




The Cochran-Armitage test of trend showed a statistically significant linear trend 
between number of trained staff and the uptake of cervical cancer screening score = 
30.307, df (1), p = .000. The Cochran-Armitage test of trend was statistically significant 
(p < .05). Therefore, the null hypothesis was rejected in favor of the alternative 
hypothesis. 
Availability of Cervical Cancer Screening Services  
The WHO has defined a set of characteristics that determine the availability of 
cancer screening services in health facilities (WHO, 2013a). In Swaziland, the service 
characteristics criteria are based on the ability to conduct visual inspection with acetic 
acid for eligible women younger than 40 years and ability to conduct a PAP smear in 
women older than 40 years (Kessler, 2017; WHO, 2013b). The characteristics for visual 
inspection with acetic acid provision are presence of speculums, acetic acid, laboratory 
whether onsite or offsite, system for results retrieval and delivery to client, availability of 
guidelines, information and educational material, and advertisement of facilities (WHO, 
2013a). These characteristics were assessed during the SARA survey conducted in 2017. 
The research question and hypotheses were:  
Research Question 2: What is the relationship between the availability of cervical 
cancer screening services in a facility and the uptake of cervical cancer screening among 
HIV-positive adolescent girls and young women in Swaziland? 
H02: There is no relationship between the availability of cancer screening services 
within a facility and the uptake of cervical cancer screening.  
Ha2: There is a relationship between the availability of cervical cancer screening 
services within a facility and the uptake of cervical cancer screening.  
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There were 10,618 AGYW eligible for cervical cancer screening: 9,956 (93.8%) 
AGYW were in 81 facilities that provided cervical cancer screening and 662 (6.2%) 
AGYW were in 37 facilities that did not provide cervical cancer screening. A total of 
2171 (20.45%) AGYW were screened: 2,077 (95.67%) AGYW were in facilities that 
provided cervical cancer screening and 94 (4.33%) AGYW were in facilities that did not 
provide cervical cancer screening. See Table 8. 
Table 8 
 
Availability of Screening Services and Cervical Cancer Screening Uptake  
    Screened   
Facility has cervical cancer screening services 
  Yes No Total 
Yes N 2077 7879 9956 
% within Cervical cancer screening services 20.9% 79.1% 100.0% 
No N 94 568 662 
% within Cervical cancer screening services 14.2% 85.8% 100.0% 
Total N 2171 8447 10618 
% of Total 20.4% 79.6% 100.0% 
 
A Chi square test of association was carried out to test for the relationship 
between two nominal/dichotomous variables: availability of cervical cancer screening 
services and uptake of cervical cancer screening (Schumacker & Tomek, 2013). My data 
met the three assumptions required to conduct a Chi square test of association: there are 
two variables, both of which were categorical, there was independence of observations 
and all cells met the expected counts of more than five (Lund Research Ltd, 2013). The 
Chi square only informs whether the null hypothesis of no association can be rejected and 
not the magnitude of any association. To assess the magnitude of any association 
detected, Phi (φ) was used (Harmatz & Greenblatt, 2015; Janzing, Balduzzi, Grosse-
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Wentrup, & Schölkopf, 2013).  Phi (φ) is a measure of the strength of association of a 
nominal by nominal relationship when the variables are dichotomous. Its range is from 
negative one to positive one (-1 to +1). 
There was a statistically significant association between availability of cervical 
cancer screening services and uptake of cervical cancer screening, χ2(1) = 16.939, p = 
0.00. There was a positive but weak association between availability of cervical cancer 
screening services and uptake of cervical cancer screening, φ = 0.04, p = 0.00. Therefore, 
we can reject the null hypothesis in favor of the alternative hypothesis. 
Additional analysis of facilities that provide cervical cancer screening. Of the 
110 facilities offering cervical cancer screening, 89.1% had speculums available, 66.4% 
had acetic acid, 1.8% had a laboratory onsite to examine samples, 64.5% had guidelines 
available, 52.7% had informational and educational material available and 32.7% 
advertised cervical cancer screening.  
A binomial logistic regression was conducted to determine whether any of these 
characteristics could predict uptake of cervical cancer screening. A binomial logistic 
regression is used to determine whether or not there is a relationship between a 
dichotomous dependent variable and two or more independent variables that may be 
categorical or continuous at the same time assessing for the potential influence of other 
explanatory variables on that relationship (Laerd Statistics, 2013; Sperandei, 2014). 
Therefore, binomial logistic regression can be used for a) controlling for other 
explanatory variables when assessing relationships between a dependent dichotomous 
variable and multiple independent variables b) predicting the probability of an event 
happening for an individual (Laerd Statistics, 2013). The main advantage of conducting a 
82 
 
binomial logistic regression is to avoid confounding effects by analyzing the association 
of all variables together. Several assumptions must be met to conduct the binomial 
logistic regression: there is one dependent variable that is dichotomous, there are one or 
more independent variables that are measured either on a continuous or nominal scale, 
there is independence of observations and the categories of the dependent and 
independent variables are mutually exclusive, the minimum number of cases per variable 
is 15, there should be a linear relationship between the continuous independent variables 
and the logit transformation of the dependent variable; there should be no 
multicollinearity; and there should be no significant outliers (Sperandei, 2014). My data 
set fulfilled all the assumptions.  
A binomial logistic regression was performed to ascertain the effects of the 
presence of equipment, diagnostics, laboratory, results return mechanism, guidelines, 
information and educational material and advertisement of services at the facilities on the 
likelihood that participants would undergo cervical cancer screening. In this model there 
were no continuous variables and no outliers.  The logistic regression model was not 
statistically significant, χ2(7) = 8.761, p =.270. The Hosmer and Lemeshow test that tests 
for goodness of fit in a regression model was not statistically significant (p = .764), 
indicating that the model is not a poor fit. The Hosmer and Lemeshow test is a 
formal test of the null hypothesis that the fitted model is correct, and its output is a p-
value- a number between 0 and 1 with higher values indicating a better fit. The model 
explained only 0.10% (Nagelkerke R2) of the variance in cervical cancer screening and 
correctly classified 82.1% of the cases. None of the seven predictor variables were 





Likelihood for Screening Based on Availability of Cervical Cancer Screening 
Infrastructure  
 B S.E. Wald df p 
Odds 
Ratio 
95% C.I. for Odds 
Ratio 
Lower Upper 
 Availability of speculums  .106 .162 .428 1 .513 1.111 .810 1.526 
Availability of acetic acid  -.067 .107 .386 1 .534 .935 .758 1.154 
Laboratory to examine 
samples 
-.048 .107 .198 1 .656 .954 .773 1.176 
Presence of a mechanism 
to return results to clients 
-.244 .166 2.150 1 .143 .784 .566 1.085 
Facility has Cervical 
cancer screening 
guidelines  
-.051 .118 .187 1 .665 .950 .754 1.198 
Facility has in-service 
communication materials 
on cervical cancer  
.059 .090 .438 1 .508 1.061 .890 1.265 
Advertisement of cervical 
cancer screening services 
-.150 .084 3.221 1 .073 .860 .730 1.014 
Constant -1.026 .367 7.815 1 .005 .358   
 
Association Between the Frequency of Services Offered and Uptake of Cervical 
Cancer Screening 
Service availability affects accessibility to the services. Service availability is 
characterized by the type of service delivery (fixed, mobile, outreach), frequency of 
service delivery (daily, weekly, monthly) and times of service delivery (8:00 – 5:00, 24 
hours; WHO, 2015). 
Almost 96% (105, 95.5%) of facilities reported offering cervical cancer screening 
on a daily basis, 3.6% (four) of facilities reported offering services twice a week and only 
0.9% (one) reported offering services thrice a week. A Chi square test of association was 
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carried out to test for the association between two nominal/dichotomous variables: 
frequency of services offered and uptake of cervical cancer screening (Schumacker & 
Tomek, 2013). My data met the three assumptions required to conduct a Chi square test 
of association: there are two variables, all of which were categorical, there was 
independence of observations and all cells met the expected counts of more than five 
(Lund Research Ltd, 2013). The Chi square only informs whether the null hypothesis of 
no association can be rejected and not the magnitude of any association. To assess the 
magnitude of any association detected, Phi (φ) was used (Harmatz & Greenblatt, 2015; 
Janzing et al., 2013). Phi (φ) is a measure of the strength of association of a nominal by 
nominal relationship when the variables are dichotomous. Its range is from -1 to +1.  A 
chi-square test for association was conducted between frequency of services offered and 
uptake of cervical cancer screening. All expected cell frequencies were greater than five. 
There was no statistically significant association between frequency of services offered 
and uptake of cervical cancer screening, χ2(2) = 0.568, p = 0.753. There was a very weak 
association between frequency of services offered and uptake of cervical cancer 
screening, φ = 0.008, p = 0.753 and therefore we cannot reject the null hypothesis in 




Figure 4. Uptake of cervical cancer screening by frequency of screening services. 
Proportion of screened adolescent girls and young women who receive their 
results within one month. On average, 40.74% (SD +/- 12.88%, range: 62%) of AGYW 
who have received cervical cancer screening and require further laboratory testing will 
receive their results within four weeks. Those in the urban areas are more likely to 
receive their results within four weeks than those in the rural areas, 46% vs 31.59%. 
There was no difference in proportion of clients who received results between facilities 
whose staff had been trained in the last two years and those who had not been trained: 
37.32% versus 37.77%.   
Core Characteristics for Cervical Cancer Screening and its Uptake  
Twenty-three (20.9%) facilities had all the core service characteristics that 
classify the facility to have cervical cancer services, 87 facilities had some of the 
characteristics and 75 facilities did not have any cervical cancer screening services. Of 
the 23 facilities with all the core service characteristics, six (26.1%) are hospitals, eleven 
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(47.8%) are clinics without maternity, two (8.7%) are public health units, two (8.7%) are 
clinics with maternity and one (4.34%) is a health center. See Table 10. 
Table 10 
 
Summary of Facilities and Core Service Characteristics for Cervical Cancer Screening  
Facility offers cervical 
screening 
Facility Type Frequency (N) Percent 
No, Does not have any 
core service characteristics 




Hospital 2 3% 
Yes, has some core service 
characteristics 




Health Center 3 3% 
Hospital 5 6% 
Public Health Unit 6 7% 
Yes, has all the core 
service characteristics 




Health Center 2 9% 
Hospital 6 26% 
Public Health Unit 2 9% 
 
Within the 23 facilities with all the core service characteristics, there were 6,434 
AGYW of whom 1197 received cervical cancer screening. In the 87 facilities that had 
some of the core service characteristics, there were 3,522 AGYW of whom 880 received 
cervical cancer screening and in the 75 facilities without any core service characteristic, 





Uptake of Cervical Cancer Screening by Availability of Core Service Characteristics  
  
Screening uptake Total 
Yes No   
All core service characteristics N 1197 5237 6434 
% within screening 
uptake 
55.1% 62.0% 60.6% 
Some core service 
characteristics 
N 880 2642 3522 
% within screening 
uptake 
40.5% 31.3% 33.2% 
No core service characteristics N 94 568 662 
% within screening 
uptake 
4.3% 6.7% 6.2% 
Total N 2171 8447 10618 
% within screening 
uptake 
100.0% 100.0% 100.0% 
 
A Cochran-Armitage test of trend was run to determine whether a linear trend 
exists between the availability of core service characteristics and the proportion of 
AGYW who received cervical cancer screening. The availability of core service 
characteristics was classified as having all core service characteristics (n = 6434), having 
some core service characteristics (n = 3522) and having no core service characteristics 
(n = 662), and the proportion of AGYW who received a cervical cancer screening was 
0.551, 0.405 and 0.043, respectively. The Cochran-Armitage test of trend showed a 
statistically significant linear trend, p = .002, with facilities having all core service 
characteristics associated with a higher proportion of AGYW who received a cervical 
cancer screening. 
The association between referrals and the uptake of cervical cancer 
screening. The uptake of health services can be enhanced by the provision of referrals to 
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clients actively by health care providers (Denno, Hoopes, & Chandra-Mouli, 2015). This 
is especially noted when those services are not available in the local health facility 
(Shannon, Vinson, Cook, & Lennon, 2016). The research question and hypothesis were: 
Research Question 3: What is the relationship between the provision of a referral 
for cervical cancer screening among eligible women and the uptake of cervical cancer 
screening among HIV-positive adolescent girls and young women in Swaziland? 
H03: There is no relationship between the provision of a referral for cervical 
cancer screening in eligible women and the uptake of cervical cancer screening. 
Ha3: There is a relationship between the provision of a referral for cervical cancer 
screening in eligible women and the uptake of cervical cancer screening. 
The data provided by HMIS did not have data on referrals for screening but rather 
referrals for further management of a positive visual inspection with acetic acid test. The 
data were also missing the outcomes of the referrals. The analysis, therefore tested for an 
association between the age of the AGYW and the provision of a referral for further 
management. HIV adolescent girls and young women who have a positive screen need to 
receive further testing and treatment as a matter of urgency as they are more likely to 
develop cervical lesions that may rapidly progress to neoplasia (Peto, 2014; Salakos, 
Paltoglou, & Top, 2014; Singh, Chilton, & Prime, 2012). However, more young women 
than adolescent girls are more likely to be referred for further testing and treatment 
because of provider bias, accessibility to services and demand side barriers (Bardají et al., 
2018; Finocchario-Kessler et al., 2016; Ghebre, Grover, Xu, Chuang, & Simonds, 2017; 
Kasting et al., 2016).  
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Of the 220 AGYW whose cervical cancer screening test was positive (49 were in 
age group 15 – 18 and 171 were in 19 - 24 age group), only 56 (25.5%) were provided 
with a referral for further evaluation. Twelve (21.43%) were in the age group 15 – 18 
years and 44 (78.57%) were in the age group 19 – 24 years. By age group, there was little 
difference between the proportion of those who were15 -18 years old and 19 -24 years 
old who received referrals: 24.5 % compared to 25.7% respectively. Hospitals provided 
most of the referrals (46.43%) followed by clinics without maternity (33.93%). Table 12 
summarizes the distribution of the AGYW who received a referral by age group, and 











Referrals to Adolescent Girls and Young Women with Positive Cervical Cancer 
Screening by Age  
    Provision of referrals 
Age Group 
 
Yes No Total 
15 - 18 years 
N 12 37 49 
% within Provision 
of referrals 21.40% 22.60% 22.30% 
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% of Total 5.50% 16.80% 22.30% 
19 - 24 years 
N 44 127 171 
% within Provision 
of referrals 78.60% 77.40% 77.70% 
% of Total 20.00% 57.70% 77.70% 
All AGYW 
N 56 164 220 




Referrals to Adolescent Girls and Young Women by Age Group and Facility Type  

















15 to 18 
years 
Yes 5 3 0 1 3 12 
No 20 8 1 2 6 37 
                
19 to 24 
years 
Yes 21 6 0 1 16 44 
No 64 21 9 2 31 127 
                
Total Yes 26 9 0 2 19 56 
  No 84 29 10 4 37 164 
  Total 109 38 10 6 57 220 
 
A chi-square test for association was conducted to test the association between 
age group of the AGYW and the provision of a referral. All expected cell frequencies 
were greater than five. There was no statistically significant association between age 
group of the AGYW and provision of a referral, χ2(1) = 0.031, p = 0.860. The association 
between age group and provision of a referral was weak as well, φ = -0.012, p = 0.860. 
Therefore, we cannot reject the null hypothesis in favor of the alternative hypothesis. 
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Difference in Uptake of Cervical Cancer Screening by Age 
Age is a determinant of cervical cancer screening both from a systems perspective 
and an individual perspective (Massad et al., 2013; Morema, Atieli, Onyango, Omondi, & 
Ouma, 2014; Salvatore Vaccarella, Lortet-Tieulent, Plummer, Franceschi, & Bray, 2013). 
Teenagers are less likely to access sexual and reproductive health services due to fear of 
discrimination and prejudice by the health facility staff and a fear of being rebuked by 
their parents whereas young women tend to be marginalized due to socioeconomic and 
cultural influences (Chapman Lambert, 2013; Morema et al., 2014; Waller, Jackowska, 
Marlow, & Wardle, 2012). HIV infected AGYW enrolled in care present a unique 
opportunity to offer cervical cancer screening routinely for eligible AGYW (Morema et 
al., 2014; Waller et al., 2012). Based on the recent Cervical Cancer Screening guidelines, 
all HIV infected girls and women (if infection was not obtained perinatally) should be 
screened at diagnosis of HIV and thereafter annually regardless of their treatment status 
(Isidean, Louvanto, & Franco, 2014; WHO, 2013b). In this study, I sought to determine 
whether there was a difference in uptake of cervical cancer screening between adolescent 
girls and young women. The research question and hypotheses were: 
Research Question 4: Is there a difference in uptake of cervical cancer screening 
between HIV-positive adolescent girls and HIV-positive young women? 
H04: There is no difference in uptake of cervical cancer screening between HIV-
positive adolescent girls and HIV-positive young women. 
Ha4: There is a difference in uptake of cervical cancer screening between HIV-
positive adolescent girls and HIV-positive young women. 
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Of the 10,618 AGYW who were eligible for cervical cancer screening, 2219 were 
in the age group 15 - 18 years and 8399 were in the 19 -24-year age group. Only 2171 
(20.44%) had received cervical cancer screening in the last 12 months. Of the 2171 
AGYW who were screened, 471 were in the age group 15 to 18 years and on 
antiretroviral therapy, 1610 were in the age group 19 to 24 years and on antiretroviral 
therapy while 10 in the age group 15 to 18 years and 90 in the age group 19 to 24 years 
were in pre-antiretroviral therapy care. Figure 5 illustrates the distribution of the AGYW 
by age group and treatment status while Table 12 provides a summary of the 
crosstabulation between Age group of the AGYW by cervical cancer screening status.  
 
 







Age Group by Screening Status  
    Screening Total 
Age Group   Yes No   
15-18 N 481 1,738 2,219 
% within Age Group 21.7% 78.3% 100.0% 
19-24 N 1690 6709 8399 
% within Age Group 20.1% 79.9% 100.0% 
Total N 2171 8447 10618 
  % of Total 20.4% 79.6% 100.0% 
 
The test of two proportions also known as the Chi-square test for homogeneity 
was used to determine the difference in uptake of cervical cancer screening between 
adolescent girls and young women. The test of two proportions can be used to assess if a 
difference exists between the proportions of two independent groups on a dichotomous 
dependent variable. Four assumptions need to be met to use this statistical test: both 
independent and dependent variables are dichotomous, the observations are independent 
of each other, the sample size should be more than 5 observations and retrospective 
purposively sampled two groups each having a specific characteristic. My dataset met all 
these assumptions and the test of two proportions was conducted. Ten thousand, six 
hundred and eighteen (10,618) AGYW were grouped according to whether they were 
adolescent girls (15 – 18 years) or young women (19 -24 years), 2,219 in the 15 – 18 year 
age group and 8,399 in the 19 – 24 year age group.  Four hundred and eighty one in the 
15 – 18 year age group (21.67%) received cervical cancer screening compared to 1,690 
(20.12%) in the 19 – 24 year age group, a non-statistically significant difference in 
proportions of 1.56, p= 0.106. The difference between the two independent binomial 
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proportions was not statistically significant (p > .05). Therefore, we fail to reject the null 
hypothesis and cannot accept the alternative hypothesis.  
Summary of Results 
Using secondary data that had been de-identified and provided by the HMIS unit 
at the Ministry of Health in Swaziland (formerly Swaziland), I studied the determinants 
of cervical cancer screening among HIV positive AG and YW enrolled in HIV care and 
treatment using three of the original four research questions:  
Research Question 1: What is the relationship between the availability of trained 
health providers and the uptake of cervical cancer screening among HIV-positive 
adolescent girls and young women in Swaziland?  
Research Question 2: What is the relationship between the availability of cervical 
cancer screening services in a facility and the uptake of cervical cancer screening among 
HIV-positive adolescent girls and young women in Swaziland? 
Research Question 4: Is there a difference in uptake of cervical cancer screening 
between HIV-positive adolescent girls and HIV-positive young women? 
For RQ 3 that was examining the relationship between the provision of a referral 
for screening and the uptake of cervical cancer screening among HIV-positive AGYW in 
Swaziland, the data provided by HMIS consisted of referrals provided to HIV-positive 
AGYW who had received a cervical cancer screening and the screen was positive. 
Therefore, I analyzed the relationship between the provision of referral for further 
management and age group of the HIV-positive AGYW.  
Most facilities (70%) had 1-2 trained staff available for cervical cancer screening 
but the most screening (35%) occurred in facilities where there were 6-10 trained staff 
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available for cervical cancer screening. A Cochran- Armitage test of trend was conducted 
to determine the presence of any linear association between number of trained staff and 
the uptake cervical cancer screening by age group. There was a statistically significant 
difference in the uptake of cervical cancer screening based on number of trained staff 
available (p= 0.00) and therefore I rejected the null hypothesis in favor of the alternate 
hypothesis.  
To determine the uptake of cervical cancer screening based on availability of 
cervical cancer screening services, I compared the AGYW who received screening in 
facilities with cervical cancer screening services and those who received screening in 
facilities without the cervical cancer screening services. There was a statistically 
significant but weak association between availability of cervical cancer screening 
services and uptake of cervical cancer screening (χ2(1) = 16.939, p = 0.00, φ = 0.008), 
therefore I rejected the null hypothesis in favor of the alternate hypothesis. Using the 
Cochran-Armitage test of trend, I also assessed the uptake of cervical cancer screening in 
those facilities that had all the characteristics, those that had some of the characteristics, 
and those that had none. AGYW who were in facilities that had all the component 
infrastructure were more likely to receive cervical cancer screening than those in facilities 
who did not have all the components (p = 0.002) and therefore I rejected the null 
hypothesis in favor of the alternate hypothesis  
I used a Chi square test of association and Phi φ to describe the association 
between frequency of service availability and uptake of cervical cancer screening. There 
was no statistically significant association between the frequency of services offered and 
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the uptake of cervical cancer screening (p=0.753) and therefore I accepted the null 
hypothesis.  
The test of two proportions was conducted to determine if there was any 
difference in uptake of cervical cancer screening in the adolescent girls compared to 
uptake among the young women. The proportions by age group of AGYW who received 
cervical cancer screening were similar: 21.67% among adolescent girls compared to 
20.12% among young women, a nonstatistically significant difference in proportions of 
1.56, p =  0.106. The difference between the two independent binomial proportions was 
not statistically significant (p > .05) and therefore, I failed to reject the null hypothesis.  
The data to test the association between cervical cancer screening and referral for 
screening were not available and the HMIS instead provided data on referral for further 
management for a positive visual inspection with acetic acid screen. This information 
was analyzed for which age group was more likely to receive a referral for further 
management for a positive visual inspection with acetic acid screen. Although more 
young women (44,78.6%) received a referral, the difference in proportions by age group 
was small: 24.5% among AG compared to 25.7% among young women and was not 
statistically significant (φ = -0.012, p=0.861) and therefore I failed to reject the null 
hypothesis. In the next section, I will discuss the interpretations of the results in context 
with the literature review, the limitations of the study, recommendations for future 




Section 4: Application to Professional Practice and Implications for Social Change  
Introduction 
The global burden of cervical cancer, a genital tract cancer caused by infection 
with HPV (Bruni et al., 2016), is mainly in the lower- and middle-income countries 
where 86% of cases occur (Bruni et al., 2016). Cervical cancer is an AIDS-defining 
illness (Chan et al., 2003), and the global distributions of HIV and cervical cancer have 
little variation, with the highest rates found in sub-Saharan Africa. In Swaziland, cervical 
cancer is the most common cause of cancer-related death among women (Swaziland 
Ministry of Health, 2015c). 
Women who are infected with HIV are at increased risk of dying from cervical 
cancer (Ghebre, Grover, Xu, Chuang, & Simonds, 2017). They are more likely to have 
persistent infections with high-risk HPV types and to have rapidly progressive 
precancerous lesions (Ginindza, Sartorius, & Za, 2018). Due to this amplified risk, 
cervical cancer screening guidelines for HIV-infected and non-HIV-infected women 
differ (Kessler, 2017; McGraw & Ferrante, 2014). The screening guidelines for adults 
and adolescents also differ. Due to the high rate of spontaneous clearance of HPV 
infections and the risks associated with over-screening among adolescents, it is 
recommended that screening does not begin until the age of 21 except if an adolescent 
girl or young woman is HIV infected (American College of Obstetritians and 
Gynecologists, 2016). HIV-infected adolescents are a high-risk population, so cervical 
cancer screening is recommended twice in the first year they are diagnosed if they are 
sexually active and annually thereafter. However, there are multiple health system factors 
that affect cervical cancer prevention: the availability of an organized screening program, 
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the existence and quality of the facilities for screening and diagnostic follow-up, and the 
facilities available for treating diagnosed lesions (Dollin, 2013; Finocchario-Kessler et 
al., 2016). But according to the Swaziland SARA 2017 report, the coverage for cervical 
cancer screening in Swaziland is 33% for all women.  
The purpose of this study was to examine the relationship between the WHO 
recommended service delivery components for cervical cancer screening (WHO, 2014a) 
and the uptake of cervical cancer screening among HIV-positive AGYW in Swaziland. I 
conducted a retrospective analytical study using secondary data from the SARA survey 
conducted in 2017 and routine clinical data that was provided by the Swaziland HMIS 
Unit. The data analysis included univariate, bivariate and multivariable analyses that 
demonstrated that the presence of trained staff and the presence of all components of a 
screening program (equipment, diagnostics, guidelines, in-service communication 
materials, laboratory and advertisement of services) had a statistically positive significant 
association with the uptake of cervical cancer screening by HIV-positive AGYW. The 
findings showed that AGYW enrolled in HIV care with facilities with a larger 
complement of staff trained on cervical cancer screening (p = 0.00) and facilities that had 
all components required for cervical cancer screening (p = 0.024) were more likely to 
receive cervical cancer screening regardless of their age group. There was no difference 
in uptake of cervical cancer screening (p = 0.104) or referral for further care (p = 1.0) by 
age group.   
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Interpretation of the Findings 
Study Findings and Past Research 
Presence of trained staff to provide cervical cancer screening and uptake of 
cervical cancer screening by HIV positive adolescent girls and young women. The 
results showed that HIV positive AGYW accessing care in facilities with larger numbers 
of staff trained on cervical cancer screening were more likely to receive cervical cancer 
screening (p = 0.00). Despite 95% of the facilities having trained staff available to offer 
cervical cancer screening, 64% of them had only one to two staff available, and the 
number of AGYW who received cervical cancer screening in these facilities was low in 
comparison to facilities that had three or more trained staff available. These findings are 
similar to other research findings. For example, Rosser et al (2015) reported that a lack of 
trained staff affects uptake of cervical cancer screening and recommended education for 
both providers and patients to improve uptake. O’Neill et al. (2013) also reviewed 
SARAs from six countries, suggesting that workforce availability and competence 
affected the provision and uptake of services. Although there may be inadequate 
infrastructure, a trained workforce is able to generate and meet demand for the service 
thereby increasing uptake and coverage of cervical cancer screening (Coleman et al., 
2016; Kim & Han, 2016). In Swaziland, where the rate of screening for all women is low 
at 33%, trained and adequate number of staff can contribute to the uptake and coverage of 
cervical cancer screening services. My findings demonstrated that it is not enough to have 
trained staff in a facility, but they must also be in adequate numbers (three or more) if the 
uptake for cervical cancer screening is to increase   
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Availability of cervical cancer screening services. I examined the association 
between the availability of cervical cancer screening services at facility level and 
AGYW’s uptake of cervical cancer screening. In a bivariate analysis, HIV-positive 
AGYW enrolled in care in facilities that had all the recommended components for a 
cervical cancer screening service were more likely to receive cervical cancer screening as 
compared to facilities with some of the components or those without any of the 
components (p = 0.02). Descriptive and logistic regression statistics for each component 
of the cervical cancer screening system further illustrated that no single component on its 
own had a statistically significant likelihood to improve cervical cancer screening uptake 
among the AGYW.   
These findings are similar to Parham et al. (2015), who attempted to scale up 
cervical cancer screening in a populous town in Zambia using low cost and low 
technology methods for screening and treating positive screens during a single visit. But 
scaling up cervical cancer screening is not feasible if all components of the screening 
service and skilled human resources are not available (Parham et al., 2015). Parham et al. 
found that facilities that did not have guidelines or equipment or a laboratory onsite were 
less likely to offer the same day service than those that had all components of the 
screening service.  
Another study related to the current study’s findings was conducted by Maseko et 
al. (2015c), who identified barriers to cervical cancer screening in Malawi, a country in 
sub-Saharan Africa with one of the highest age-standardized incidence rates of cervical 
cancer. Maseko et al. found that there was a lack of policies, lack of trained human 
resources and lack of equipment and diagnostics to conduct the screening, that limited 
101 
 
cervical cancer screening services for eligible women. The barriers to the uptake of 
cervical cancer screening can be categorized as individual, community, and health 
system. Therefore, to improve the uptake of cervical cancer screening in any country, all 
three of these categories need to be addressed simultaneously to generate demand, 
address stigma, and improve supply for cervical cancer screening (Maseko et al., 2015b). 
I also found that the uptake of cervical cancer screening was higher in the presence of all 
components of service delivery (guidelines, equipment, diagnostics, laboratory services 
and a results return mechanism, in-service communication and advertisement of the 
services) than when some of the components were missing or there was no service at all 
that is supported by previous findings and reaffirms the need for the Ministry of Health to 
ensure that all service components are available at each level of the health system 
(clinics, health centers, and hospitals). 
Provision of referrals for further management of a positive screening test. 
The timely and appropriate referral for further management of a positive screening test 
improves the outcomes of cervical cancer, especially in HIV-infected adolescent girls. 
High rates of cervical lesions in adolescent girls are due to high rates of HPV infection 
(Foxx et al., 2017; Kerrebroeck & Makar, 2016). However, these lesions clear away 
spontaneously in 90% of the population who are not HIV infected (Foxx et al., 2017). In 
HIV-infected adolescent girls, many of these lesions do not clear away and rapidly 
progress into precancerous and cancerous lesions, making referral for further 
management vital for early diagnosis, prevention, and treatment of cervical cancer in this 
age group (Ghebre et al., 2017). There was a non-statistically significant difference in 
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proportions of adolescent girls who were referred for further care (24.5%) compared to 
the proportion of young women who were referred for further care (25.7%), p = 0.860.     
These findings are comparable to studies in Malawi, a country with high HIV 
prevalence and incidence among AGYW and the highest age standardized incident rates 
of cervical cancer in the world. Based on findings from the Malawi Population-Based 
HIV Impact Assessment 2015-2016, HIV-infected adolescent girls enrolled in HIV care 
were less likely to receive cervical cancer screening and referrals for further management 
compared to older age groups (Jonnalagadda et al., 2018), and younger women with 
positive cervical cancer screens were less likely to receive follow up for further treatment 
(Msyamboza, Phiri, Sichali, Kwenda, & Kachale, 2016a). This is because younger age 
groups were less likely to complete follow up or have the resources to go to a treatment 
facility and service providers did not prioritize younger age groups for referrals. 
Swaziland is similar to Malawi in that HIV-positive adolescent girls with a positive 
cervical cancer screen are not referred any differently than HIV-positive young women, a 
situation that needs to be addressed. Because of the lack of follow up in this population, it 
would be important to either offer same day treatment on site or have a mechanism to 
follow up these adolescent girls to ensure that they receive the appropriate treatment. 
Difference in cervical cancer screening uptake by age group. Older women are 
more likely to receive cervical cancer screening due to less discrimination around 
sexuality and generally sexual reproductive health services are more user friendly for 
them than for adolescent girls (Boardman & Robison, 2013; Ghebre et al., 2017). I 
compared two age-groups: adolescent girls (15–18) and young women (19–24). Findings 
of a bivariate analysis showed that there was no statistically significant difference in 
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proportions of adolescent girls who received cervical cancer screening (21.7%) and the 
proportion of young women who received cervical cancer screening (20%), p = 0.106.    
These findings from this study do not align with findings from previous studies. 
In South Africa, where HIV and cervical cancer incidence and prevalence is similar to 
Swaziland, HIV-infected adolescents were less likely to receive cervical cancer screening 
than HIV-infected young women because health care providers are not knowledgeable on 
risk of cervical cancer among adolescents and adolescent-friendly health services are not 
common despite adolescent girls being a high risk population (Hoque, Ghuman, 
Coopoosmay, Van Hal, 2014; Hoque, Ghuman, & Van Hal, 2013; Hoque Monokoane, & 
Van Hal, 2014). In addition, in Nigeria, where HPV vaccination is not institutionalized, 
routine cervical cancer screening is offered to women above the age of 21 regardless of 
their HIV status, and cervical examinations in adolescents are only conducted if there are 
specific complaints that skews the uptake of cervical cancer screening in HIV-infected 
AGYW to only young women (Ahmed, Ahmed, Idris, & Sabitu, 2013; Awodele et al., 
2011; Ugwu, Obi, Ezechukwu, Okafor, & Ugwu, 2013). In countries where HPV 
vaccination is being rolled out or scaled up, it has been demonstrated that adolescent 
girls’ knowledge of cervical cancer and their risk for cervical cancer is very low 
regardless of their HIV status (Jain, Halder, & Mehrotra, 2016; Kim & Han, 2016; 
Leinonen et al., 2017; Subramanian et al., 2016). Implementing strategies to improve 
uptake of cervical cancer screening among HIV-infected AGYW equally is a 
recommended best practice. Although Swaziland screens them equally, with the current 
cervical cancer screening uptake rate among AGYW at only 21.5%, the effort needs to 
increase to ensure that all HIV-positive AGYW receive cervical cancer screening 
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according to the guidelines. The results from Swaziland may be dissimilar to other areas 
because most of the HIV-positive adolescent girls in Swaziland are receiving their care in 
hospitals and health centers that run special adolescent clinics and have more trained staff 
available to offer the service.  
Study Findings and Systems Thinking Theory 
This study used the systems thinking theory that posits that multiple elements 
with dynamic processes influence a given outcome at varying levels. The systems 
thinking theory has been used to improve health outcomes by understanding the 
functioning and interactions of elements involved in providing care for patients and the 
multiple determinants of health at different levels of the health system (Cordon, 2013). 
The more complex the health care required by the patient for example those with HIV 
infection, the more likely they are to experience multiple incidences of harm including 
the loss of dignity and respect (Classen et al., 2011; Levinson, 2010, 2012). One instance 
of harm is the failure to provide patient with relevant care, for instance HIV infected 
AGYW who should receive cervical cancer screening but do not (Peters, 2014). I 
examined the health system components of trained health providers, service delivery, and 
referrals as determinants of the uptake of cervical cancer screening among HIV positive 
AGYW. The findings of the study support the systems thinking theory by showing that 
HIV positive AGYW enrolled in care in facilities that provide all service delivery 
components and had a large enough trained staff complement were more likely to receive 
cervical cancer screening than those enrolled in care in facilities that had few or no 
trained staff or those enrolled in care in facilities that had some of the service delivery 
components or none at all. The systems thinking theory was useful in guiding the 
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identification of the study deliverables including the breakdown of the service delivery 
elements, the design of the study questions, analysis and the interpretation of the findings.   
Limitations of the Study 
I used secondary quantitative data that was not purposely collected for this study 
and some of the variables were not available for analysis, such as data on the provision of 
referrals for cervical cancer screening for AGYW who are in facilities that do not offer 
cervical cancer screening in the original context of the study. The service delivery data 
were of a cross-sectional nature collected at one point in time (Sedgwick, 2014a) and 
therefore it was not possible to determine any causal inferences, nor explanatory 
dimensions to observations. It also did not allow for sequencing of events between 
independent and dependent variables nor any trend analysis on the study outcome 
(Alexander, Lopes, Ricchetti-Masterson, & Yeatts, 2014; Van der Stede, 2014). 
I did not collect information from the target population directly, and therefore 
could not assess the demand side factors of a health system that potentially could affect 
the uptake of cervical cancer screening. Factors like facility waiting times, distance to the 
health facility, education level and other socioeconomic characteristics are important 
factors that would have provided greater insights into the relationship between demand 
for cervical cancer screening and the uptake of cervical cancer screening. In Nigeria and 
in the United States, a low uptake of cervical cancer screening exists despite having all 
the service delivery components. The low uptake is attributed to women’s perceptions of 
risk and stigma that prevent them from using the services regardless of the availability of 
services and trained staff. In Nigeria, a low level of knowledge about cervical cancer and 
its prevention were identified as the major determinants of low cervical cancer screening 
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uptake (Nwobodo & Ba-Break, 2016) whereas in the United States, health care system 
distrust was a barrier to cervical cancer screening even after controlling for demographic, 
socioeconomic and service delivery determinants (Yang, Matthews, & Hillemeier, 2011). 
Other essential dimensions of health system determinants not covered in this study 
include leadership, political will as well as financing for cervical cancer screening in the 
country. The non-interventional nature of the study did not allow any cause- and-effect 
analysis in the absence of variable manipulation.  
Recommendations for Further Research 
I have highlighted the important role of the availability of adequate numbers of 
trained staff and the availability of all service delivery components in influencing the 
uptake of cervical cancer screening in Swaziland. I found some data gaps in the health 
information system relating to the referral of patients for services that were not available 
within the facility that would need to be addressed to strengthen the health sector referral 
and linkages systems as part of the Universal Health Coverage goals (Wong, 2015). 
I recommend that researchers conducting studies on the determinants of cervical 
cancer screening uptake and coverage should consider the inclusion of other health 
system characteristics mentioned above that were not measured in this study to foster a 
much better understanding of health facility related dynamics on the uptake of cervical 
cancer screening among HIV positive AGYW.  Additionally, the cross-sectional 
quantitative nature of this study did not allow any causal inferences, nor explanatory 
dimensions to the findings and therefore a mixed-methods or a prospective study of 
uptake of cervical cancer screening could help provide an in-depth understanding of the 
107 
 
demand and supply dynamics for the uptake of cervical cancer screening as well as 
establish cause-and-effect relationships or associations among the independent variables.  
Implications 
Implications for Practice 
While it is ideal to take a holistic approach in addressing the health system 
barriers to uptake of cervical cancer screening in HIV positive AGYW, the current 
financial climate in Swaziland precludes the Ministry of Health from doing so and 
therefore prioritization of interventions based on their potential to maximize impact will 
be necessary (Swaziland Ministry of Health, 2015a). The information generated from this 
study may play a significant role in providing the evidence to design the cervical cancer 
service delivery interventions to improve the uptake of screening services. The findings 
point to three intervention areas: adequacy of numbers of trained health providers, 
availability of all components for screening service delivery at the facility level, and 
referrals of HIV positive adolescent girls for further management once they have a 
positive screening test.   
Like many lower- and middle-income countries, Swaziland experiences a human 
resource for health shortage compounded with a maldistribution of existing human 
resource between rural and urban areas (Campbell et al., 2013; Fulton et al., 2011; Spero, 
McQuide, & Matte, 2011). Although the Ministry of Health drafted a task shifting brief 
in 2010, no further progress has been made to finalize and implement this policy that 
would encourage cross-training and redistribution of roles and scope of practice for 
doctors, nurses and other lay health providers (Fulton et al., 2011). Information generated 
by this study could be used to provide a rationale to finalize and pilot the policy.  
108 
 
Secondly, procurement and supply chain management systems both at national 
and facility levels should be strengthened to ensure that the diagnostics (acetic acid) and 
equipment (speculum) to conduct the screening are continuously in stock and minimize 
missed opportunities to screen HIV positive AGYW who are accessing HIV care and 
treatment in the same clinics.  
Robust referral and linkage mechanisms within a health system ensure that clients 
are retained in care and receive appropriate follow up for their disease condition (Belhadj, 
Rasanathan, Denny, & Broutet, 2013; Mwaka, Wabinga, & Mayanja-Kizza, 2013; 
Nakisige, Schwartz, & Ndira, 2017). Ensuring that there is a reflexive referral mechanism 
for the most vulnerable or high-risk clients provides a return on investment in terms of 
less morbidity (less disease complications) and less cost in treating them (Binagwaho et 
al., 2013; Mwaka et al., 2013). The Ministry of Health could adopt best practices from 
elsewhere to ensure that HIV positive adolescent girls receive the referrals they need and 
are linked to care to ensure the best health outcomes for them.  
Implications for Positive Social Change 
I examined a crucial health issue affecting a vulnerable and priority population in 
Swaziland. With a youth bulge in the population and 30% of new HIV infections 
occurring in women aged 15 – 24 years (Ginindza et al., 2018), preventing additional 
morbidity from cervical cancer in this population is not only necessary but mandatory. 
The uptake of cervical cancer screening in women in Swaziland remains sub-optimal 
even in facilities where the services are routinely available, and this is even more 
pronounced in AGYW. A limited understanding of the drivers of uptake of cervical 
cancer screening may have contributed to this situation. 
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I hope to foster positive social change by generating knowledge on the 
institutional level health system factors that contribute to the low uptake of cervical 
cancer screening among HIV-positive AGYW in Swaziland. This knowledge may help 
policy makers, health managers, and service providers understand how to strengthen the 
health system to improve uptake and, in the longer-term, coverage of cervical cancer 
screening services in Swaziland.  
The findings, if used contextually, could inform any public health interventions 
aimed at improving uptake to cervical cancer screening in HIV positive AGYW in 
similar settings, and ultimately reduce the high costs, morbidity and mortality related to 
cervical cancer in this population. 
For these reasons, the dissemination of the study findings will target the 
Swaziland Ministry of Health and health facilities, the Ministry of Education, the Private 
health sector and Community Based Organizations that work with adolescent girls and 
young women. Local civil society organizations will also be targeted through policy, and 
program strategic and implementation meetings, workshops and conferences. I will 
publish the study findings in at least one peer-reviewed journal to further share its 
findings with the international community. 
Conclusion 
The low uptake of cervical cancer screening in the absence of widespread HPV 
vaccination in low- and middle-income countries like Swaziland that have high incident 
rates of Cervical cancer, demonstrates the urgent need for innovative interventions to 
provide screening for this preventable and curable cancer (Coleman et al., 2016; Ghebre 
et al., 2017).  
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This information produced by my research may be useful to guide the Swaziland 
Ministry of Health in the allocation of resources for cervical cancer screening within 
health facilities as well as inform country guidance and implementation plans. Further 
research is needed to understand the demand side drivers that influence the uptake of 
cervical cancer screening by HIV positive AGYW in Swaziland at both individual and 
institutional levels. However, the findings from this study support the hypotheses that 
adequate numbers of trained providers and the availability of all components of cervical 
cancer screening services influence the uptake of cervical cancer screening among HIV 
positive AGYW and I suggest that more emphasis needs to be placed on referring the 
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